As Filed with the Securities and Exchange Commission on July 9, 1999
                                                    Registration No. 333-_______

- --------------------------------------------------------------------------------

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                 ---------------

                        FORM SB-2, REGISTRATION STATEMENT
                        UNDER THE SECURITIES ACT OF 1933

                                 ---------------

                                 Docuport, Inc.
                 (Name of small business issuer in its charter)

           Delaware                        3577                  22-3649272
                                         (Primary
(State or other jurisdiction of     Standard Industrial       (I.R.S. Employer
 incorporation or organization)    Classification Number)    Identification No.)

                      1155 Rene Levesque West - Suite 3500
                                   P.O. Box 60
                          Montreal, PQ, H3B 3T6, Canada
                                 (514) 878-0098
                        (Address and telephone number of
               principal executive offices and place of business)

                Raja S. Tuli, Chairman of the Board of Directors
                                 Docuport, Inc.
                      1155 Rene Levesque West - Suite 3500
                                   P.O. Box 60
                          Montreal, PQ, H3B 3T6, Canada
                                 (514) 878-0098
                                 (514) 866-3630
                          (Name, address and telephone
                          number of agent for service)

                                   Copies to:

                            Frederick M. Mintz, Esq.
                              Mintz & Fraade, P.C.
                               488 Madison Avenue
                            New York, New York 10022
                          Telephone No.: (212) 486-2500
                          Facsimile No.: (212) 486-0701

                                 ---------------

      Approximate date of proposed sale to the public:

      As soon as practicable after this Registration Statement becomes
effective.

      If any of the securities being registered on this form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act
of 1933, check the following box. |X|

      If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, please check the following box and list the Securities
Act registration statement number of the earlier effective registration
statement for the same offering. |_| ______________________.

      If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. |_|



      The Registrant hereby amends this Registration Statement on such date or
dates as may be necessary to delay its effective date until the Registrant shall
file a further amendment which specifically states that this Registration
Statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933 or until the Registration Statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a),
may determine.

                        CALCULATION OF REGISTRATION FEE



- -------------------------------------------------------------------------------------------------
                                                                 Proposed
Title of securities    Amount to be          Proposed             Maximum            Amount of
        to            registered (1)          Maximum            Aggregate       registration fee
   be registered                          Offering Price      Offering Price
                                             Per Share
- -------------------------------------------------------------------------------------------------
                                                                          
   Common Stock,
 par value $0.001        1,233,333             $2.00            $2,466,666            $685.73
- -------------------------------------------------------------------------------------------------


(1) Estimated solely for the purpose of calculating the registration fee
pursuant to Rule 457(c).

      This prospectus relates to 1,233,333 shares of our common stock owned by
the persons named in this prospectus under the caption "Selling Stockholders."
The shares were acquired by the selling stockholders in various transactions,
all of which were exempt from registration under the Securities Act of 1933, as
amended. The shares registered by this prospectus may be offered from time to
time by the selling stockholders through ordinary brokerage transactions in the
over-the-counter market, in negotiated transactions or through other commonly
used methods to trade publicly available stock, at market prices prevailing at
the time of sale or negotiated prices. The shares of our common stock may be
sold directly or through brokers or dealers.

      We will receive no part of the proceeds of any sales of our common stock
as a result of this registration. We will bear all the costs and expenses
associated with the preparation and filing of this registration statement.



                    SUBJECT TO COMPLETION, DATED July 9, 1999

PROSPECTUS

                               1,233,333 Shares

                                 DOCUPORT, INC

                                 Common Stock

      This is the first registration of our securities. The common stock
available for sale as a result of this prospectus will be sold by currently
existing stockholders. We will not receive any money from the sale of our common
stock as a result of this registration.

                           ------------------------

      We have not yet begun operations and are still in the development stage.
These are speculative securities which pose a high degree of risk to investors.
An investor should read the Risk Factors section of this Prospectus, located on
page 4 before deciding whether to invest in these securities.

                           ------------------------

      Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a
criminal offense.

                   The date of this Prospectus is   __, 1999



                               TABLE OF CONTENTS
                                                                           Page
                                                                           ----
Prospectus Summary...........................................................1
Summary Financial Information............................................... 3
Risk Factors.................................................................4
Use of Proceeds.............................................................11
Capitalization..............................................................11
Management's Discussion and Analysis of Financial Condition and
Results of Operations ......................................................11
Financial Condition and Results of Operations...............................13
Business....................................................................16
Dividend Policy.............................................................22
Employees...................................................................22
Management..................................................................23
Executive Compensation......................................................25
Certain Relationships and Transactions......................................26
Principal Stockholders......................................................28
Plan of Distribution........................................................29
Description of the Securities...............................................33
Shares Eligible for Future Sale.............................................35
Legal Matters...............................................................36
Experts.....................................................................37
Available Information.......................................................37
Index to Financial Statements............................................F - 1



                                   SUMMARY

      The following summary highlights certain information from this prospectus
and may not contain all the information you may find important to your decision
to invest in our securities. To understand this prospectus fully, you should
read the entire prospectus carefully, including the financial information
following this prospectus.

      For simplicity, we use the terms "we" and "our" to refer both to the
corporation originally founded as Docuport, Inc. under the laws of Ontario,
Canada and which became our wholly owned subsidiary following our March, 1999
private offering and the entity that was incorporated in the State of Delaware
on March 24, 1999 and whose common stock is the subject of this prospectus. At
times we will refer to Docuport Canada and Docuport Delaware for purposes of
distinguishing the two entities.

Our Business

      We were incorporated in the State of Delaware in March, 1999. We are the
parent corporation of Docuport, Inc, a corporation incorporated under the laws
of Ontario, Canada in February, 1992 under the name Slimfax, Inc. The Canadian
corporation was founded by our Chairman of the Board of Directors, Mr. Raja S.
Tuli. We have developed and intend to market and sell a patented, portable
multifunctional office machine called the Slimfax. The Slimfax's dimensions are
12.5" x 3" x 1.24"; and it is a combination: (1) full page fax machine, (2) full
page scanner, (3) full page printer, (4) full page copier and (5) fax/data
modem. Full page means 8.5" x any length. The Slimfax weighs approximately 2.1
lbs. It utilizes a power supply consisting of either a DC connector which
conveniently plugs into any electrical outlet; a rechargeable Nickel Metal
Hydride battery or an AC adapter to plug into the cigarette lighter of a car or
boat. We are unaware of any other product currently on the market which
possesses these multifunctional capabilities in this size and weight.

      Management believes that the Slimfax has an advantage over its present and
future competitors because of the pricing, distribution and support strategies
which Management intends to utilize. Management has no knowledge that any other
company presently makes a portable product such as the Slimfax that incorporates
a fax machine, copier, scanner, data modem and printer in one unit. Furthermore,
the intended price of the Slimfax would make it affordable to a wide segment of
the population. We intend to have a strategic marketing and promotion campaign
which shall focus upon educating distributors and potential users about the
technology and the Slimfax benefits.

      Although at the present time we have not finalized any distribution
arrangements, it is our intention that the Slimfax will be sold through the
following distribution channels : (i) Direct Marketing; (ii)
Dealers/Distributors; (iii) Retail; (iv) Original Equipment Manufacturers who
will use their own name on the Slimfax; (v) System Integrators, which package
several products together offering a full service integrated product; (vi) Value
Added Resellers, who upgrade and repackage products for marketing; and (vii) the
Internet to market directly to users of the product.


                                       1


      We intend to improve the Slimfax by developing and producing features such
as color, speed and higher resolution. We are also developing a Portable
Pen-Size Scanner which will be 8.5" in length with an outside diameter of 1/4"
and weighing 2.5 ounces, making the Portable Pen-Size Scanner easy to use and
permitting convenience of remote use. We anticipate completing development of a
prototype within two months and starting production of the Portable Pen-Size
Scanner within the next six months.

      Our products are designed for relative ease of use and portability. It is
not necessary for a user of our products to have a detailed understanding of
computer technology. Our products are specifically designed to benefit users by
allowing individuals to engage in mobile use of their computers while
maintaining contact with their clients and office from remote locations.

      On August 12, 1998, we entered into a non-binding letter of intent with
Pentax Technologies to market the Slimfax by entering into a private label
agreement, pursuant to which Pentax would sell the Slimfax under its own label,
as a Pentax product. There can be no assurance that this transaction will
proceed.

      On April, 15, 1999 we entered into a Marketing and Sales Agreement with
Solutions Plus, Inc. (See "Certain Relationships and Transactions") This
agreement provides that Solutions Plus, Inc. will be responsible for our sales
and marketing operations on a non-exclusive basis. Its responsibilities include
the marketing and sale of the Slimfax, as well as maintenance of our books,
records and financial accounts. We are still in the planning stages of our
development and have not begun sales of the Slimfax. Part of our agreement with
Solutions Plus, Inc. is to plan a marketing and sales strategy for the
introduction of the Slimfax into the retail sales market.

      Our executive offices are located at 1155 Rene Levesque West, Suite 3500,
P.O.Box 60, Montreal, PQ, H3B 3T6, Canada. The telephone number in Canada is
(514) 878-0098 and the facsimile number is (514) 866-3630. Our United States
offices are located at 81 Two Bridges Road, Fairfield, New Jersey 07005. The
telephone number in New Jersey is (973) 882-3177 and the facsimile number is
(973) 882-5340.


                                       2


                         SUMMARY FINANCIAL INFORMATION

   Since the Delaware corporation was formed on March 24, 1999 and we did not
commence operations through the Delaware corporation until after March 31, 1999
the following data has been derived from the financial statements of our
Canadian subsidiary and should be read in conjunction with those statements,
which are included in this prospectus and expressed in U.S. dollars.

                                     AUDITED



                                                              From Inception                        12 Months Ending December 31,
                                                              February 1, 1992
                                                              through December 31, 1998            1998                        1997
                                                                                                                 
Statement of Operations Data:
Net Revenue ....................................                         $0                          $0                          $0
Interest Income ................................                    $11,152                        $113                      $6,124
Total Expenses .................................                   $683,334                    $156,592                    $329,446
Net Loss .......................................                  $(672,182)                  $(156,479)                  $(323,322)

Balance Sheet Data:
Working Capital ................................                                              $(621,438)                  $(500,610)
Total Assets ...................................                                               $153,523                    $173,243
Total Liabilities ..............................                                               $767,894                    $663,588
Stockholders' Equity (Deficiency)(1) ...........                                              $(614,371)                  $(490,345)



                                    UNAUDITED



                                                              From Inception                           3 Months Ending March 31,
                                                              February 1, 1992
                                                              through March 31, 1998               1998                        1997
                                                                                                                 
Statement of Operations Data:
Net Revenue ....................................                         $0                          $0                          $0
Interest Income ................................                    $11,152                          $0                          $0
Total Expenses .................................                   $757,231                     $73,897                     $23,311
Net Loss .......................................                  $(746,079)                   $(73,897)                   $(23,221)

                                                                                                Actual      Proforma(2)      Actual
Balance Sheet Data:
Working Capital ................................                                              $(705,649)      $84,351     $(533,075)
Total Assets ...................................                                                $60,144      $850,144      $166,981
Total Liabilities ..............................                                               $759,003      $759,003      $690,353
Stockholders' Equity (Deficiency)(1) ...........                                              $(698,859)      $91,141     $(523,372)



                                       3


(1) Amounts indicated do not include shares of our common stock underlying each
common stock purchase warrant held by investors in the 1996 private offering.
(2) Amounts indicated include (A) 700,000 shares of our common stock issued
pursuant to a private offering commenced in March, 1999 by Docuport Delaware,
which closed in April, 1999; and (B) 435,000 shares of our common stock issued
pursuant to a private offering in April, 1999 by Docuport Delaware. In view of
the fact that Docuport Delaware was incorporated on March 24, 1999 there were no
financial results to the United States entity until after March 31, 1999 and
accordingly, only the proforma presentation reflects the Docuport Delaware's
initial raise of capital in April, 1999.

                                  RISK FACTORS

      An investment in our common stock involves a high degree of risk. You
should read these risks described below before making any investment decisions,
however, the following risk factors are not intended to be an exhaustive list of
the general or specific risks relating to the purchase of our common stock and
additional risk factors are described throughout this registration statement. If
any of the following risks actually occur, our business, financial condition and
operations will be materially affected.

We do not have an operating history to evaluate our future performance

      We have not yet begun operations. As a result, you will not be able to
predict our future financial condition based upon our past performance.

Computer technology is subject to rapid change and advancement

      Because we are entering a highly competitive market you should be aware of
the difficulties we will likely encounter. Portable peripheral technology has
been in existence since the early 1990's. The computer technology market is
subject to significant change and advancement which results in short product
life cycles and rapid price declines. The development of new and better
technologies, may render our products obsolete or have a material adverse effect
upon our business. Our future prospects are highly dependent upon our ability to
increase our products functions and to develop new products which address new
technologies and receive market acceptance. We believe that our products and
technology are sufficiently advanced so as to insulate us from technical
obsolescence for a number of years. There are numerous manufacturers of portable
peripheral technology which have substantially greater financial and technical
resources and production and marketing capabilities than we do. These
competitors may be able to bring new, better and cheaper products to the market
more quickly than we can.

The failure to be year 2000 compliant by either third parties or us may
materially affect our operations

      The issue known commonly as "Y2K" refers to the inability of many
computers and


                                       4


computer software to recognize the changing of the millennium to the year 2000.
Thus, date sensitive computers and related software which have not been properly
programmed will recognize the change in years of December 31, 1999 to January 1,
2000 as January 1, 1900. We are reviewing our current systems and believe that
our technology is year 2000 compliant. However, there can be no assurance that
all of our internal systems, devices and applications will be 2000 compliant.

      We place a high degree of reliance upon computer systems of third parties,
such as customers, trade suppliers and computer hardware and commercial software
suppliers. Although we are assessing the readiness of these third parties and
preparing contingency plans if they are not 2000 compliant, there can be no
assurance that the failure of these third parties to modify their systems prior
to December 31, 1999, would not have an adverse effect upon our business.

      In addition, we believe that our products should work effectively with
other technology which may not be 2000 compliant. However, there can be no
assurance with respect to the effect the failure to be year 2000 compliant will
have upon our products or that our products will not be affected by the year
2000 problem.

We Will Need Additional Financing to Continue to Develop Our Products

      We will need additional financing to meet our capital requirements. We
currently have no arrangements to obtain additional financing and we will be
dependent upon sources such as: (i) future earnings, and (ii) the availability
of funds from private sources such as, loans and additional private placements.
In view of our lack of an operating history, our ability to obtain additional
funds is limited. Additional financing may only be, if at all, upon terms which
may not be commercially advantageous. If adequate funds are not available from
operations or additional sources of financing, our business will be materially
adversely affected.

We will be competing with numerous larger and more financially established
companies

      The market for our products is highly competitive and is characterized by
pressures to reduce prices, incorporate new features and accelerate the release
of new product versions. There are numerous companies which offer products in
the portable peripheral market which compete directly or indirectly with our
products. These competitors have substantially greater financial and technical
resources and production and marketing capabilities than we do. Competitors with
superior resources may be able to bring newer, better and cheaper products to
market more quickly than we are capable of doing. We will be competing with:

      o     Multi-function and single use portable product manufacturers such as
            Toshiba, Hewlett Packard and Xerox; and

      o     Local businesses which provide the same services which can be
            performed by the SlimFax, such as copy centers and computer rental
            service providers.

      We believe the early timing of the Slimfax in the portable peripheral
market, the United States patent which we own and the patents we are applying
for, should give us a competitive edge in


                                       5


the portable peripheral market. It should take several years of research and
development efforts before competitors can design and develop a comparable
product. However, there can be no assurance that our competitors will not
succeed in developing and marketing comparable products at a future date which
could prove to be equally or more effective than those we develop or acquire or
which could render our products obsolete or non-competitive. A variety of other
potential actions by our competitors, including increased promotion and
accelerated introduction of new of enhanced products, could have a material
adverse impact upon the results of our operations. There can be no assurance
that we will be able to successfully compete with such promotions in the future.

We expect to incur significant losses for the foreseeable future

      We expect to incur significant losses on both a quarterly and an annual
basis for the foreseeable future. There can be no assurance that we will ever
achieve profitability. Our revenues and operating results may also fluctuate.

We have not declared any dividends on our common stock

      To date, we have not paid dividends on our common stock and at the present
time, we intend to retain earnings, if any, for our development and expansion.
There can be no assurance that we will have sufficient earnings to pay any
dividends on our common stock. In addition, even if we have sufficient earnings,
we are not obligated to declare dividends on our common stock. Future
declarations of any cash or stock dividends will be in our board's sole and
absolute discretion and will depend on our earnings, capital requirements,
financial position, general economic conditions and other pertinent factors. It
is also possible that the terms of any future debt financing may restrict the
payment of dividends.

We may be subject to the SEC's "penny stock" rules if our common stock is below
$5.00 per share

      If, after our stock begins to trade, the trading price of our common stock
is below $5.00 per share, trading in our securities would be subject to the
requirements of the SEC's rules with respect to securities trading below $5.00,
which are referred to as "penny stocks". These rules require the delivery prior
to any transaction of a disclosure schedule explaining the penny stock market
and all associated risks and impose various sales practice requirements on
broker-dealers who sell "penny stocks" to persons other than established
customers and accredited investors, which are generally defined as institutions
or an investor individually or with their spouse, who has a net worth exceeding
$1,000,000 or annual income, individually exceeding $200,000 or, with their
spouse, exceeding $300,000. For these types of transactions the broker-dealer
must make a special suitability determination for the purchaser and have
received the purchaser's written consent to the transaction prior to the sale.
In addition, broker-dealers must disclose commissions payable to both the
broker-dealer and the registered representative and current quotations for the
securities they offer. The additional burdens imposed upon broker-dealers by
such requirements may discourage broker-dealers from effecting transactions in
our common stock which could severely limit its market price and liquidity.


                                       6


We may not be able to protect our proprietary rights

      We rely, and intend to rely upon the patent which has been granted to us
and the patent applications we have filed and intend to file with the United
States Patent and Trademark Office to protect our rights to the technology we
have developed. Our exclusive right to develop and use this technology is
essential to our introduction into the technology market. However, there can be
no assurance that we will be able to protect and enforce these rights against
companies which attempt to copy our technology or improve upon our designs.

Our success depends upon the continued employment of our executives and certain
key employees

      We intend to substantially depend upon the continued services of our
President and Chief Executive Officer, Mr. Norman Docteroff, for management,
sales and marketing of the Slimfax. In addition, we substantially depend upon
our founder, Chairman of the Board of Directors, Mr. Raja S. Tuli, for advances
in our technology and development of new products. The loss of the services of
Mr. Docteroff or Mr. Tuli would have a material adverse affect upon our business
and our prospects. We have not entered into employment agreements with any of
our key personnel, other than with Mr. Docteroff. We do not maintain "key man"
life insurance on the life of any of our employees. To the extent that the
services of key personnel become unavailable, we will be required to retain
other qualified persons and there can be no assurance that we will be able to
employ qualified persons upon acceptable terms.

      In addition, our success is dependent upon our ability to attract and
retain highly qualified personnel. Competition for such personnel is intense and
there can be no assurance that we will be able to attract and retain the
personnel necessary for the development and operation of our business. The loss
of the services of any such personnel may have a material adverse effect upon
our financial condition and our existing or planned operations.

Government regulations of technology could affect production and sale of our
product

      Our operations are subject to regulations applicable to our products and
business operations such as:

      o     import and export regulations;
      o     minimum product safety regulations; and
      o     federal and state tax regulations.

      We intend to fully comply with applicable regulations, there can be no
assurance of our ability to do so. If we are unable to comply with such
regulations, such noncompliance may have an adverse effect upon our operations.

We may not engage in future product development


                                       7


      Our plans to engage in future development of the Slimfax and other
products are based upon factors such as:

      o     our profitability from the sale of the Slimfax;

      o     our ability to raise additional financing other than from
            operations; and

      o     the recruitment of sufficient personnel for sales, marketing and
            technology development for future products;

There can be no assurance that we will engage in future product development or
that such new product development will be successful.

You may not have a significant impact upon controlling our affairs

      Mr. Raja S. Tuli and members of his immediate family (Raja S. Tuli and
members of his immediate family are hereinafter collectively referred to as the
"Tuli family shareholders") own approximately 58% of our issued and outstanding
common stock. The Tuli family stockholders have agreed that for a period of five
years commencing April 1, 1999, our board will consist of five board members and
that two of our directors will be outside directors, who are directors whom we
do not employ. We have only one outside director as of the date of this
prospectus. Our President and Chief Executive Officer, Norman Docteroff is also
a director. We anticipate that a second outside director will soon be elected by
our shareholders other than the Tuli family stockholders. This agreement also
provides that for this five year period the Tuli family stockholders will not
have the right to participate in a vote to elect the outside directors. The
outside directors will, therefore be elected by a majority of our other
stockholders. This agreement will remain in effect for five years unless an
underwriter of a future registration of our securities requests that this be
changed. Whether or not to comply with the underwriter's request will be in the
sole and absolute discretion of the Tuli family stockholders. Even though our
outside directors will be elected by stockholders other than the Tuli family
stockholders, the Tuli family stockholders will control our management and
affairs. After the five year period, based upon their present ownership
percentage of our issued and outstanding common stock, the Tuli family
stockholders, will have the power to elect all of our directors.

The market for our securities is unsure and may be volatile

      There is no current market for our securities and there can be no
assurance that a market will exist in the future. In addition, if a trading
market does develop, there can be no assurance that our common stock can be
resold either at or near its original offering prices. We intend to arrange to
list our common stock on the NASD Bulletin Board. However, there can be no
assurance that we will qualify for such listing.

We engage in transactions in foreign currency which are subject to fluctuations
in the exchange rate

      We conduct a substantial number of transactions in foreign currency,
primarily the Canadian


                                       8


dollar and, to a lesser extent, the Indian rupee. Fluctuations in the exchange
rates between the United States dollar and the Canadian dollar or Indian rupee,
could have an adverse affect upon our operating results in the future. We may
seek to limit our exposure to the risk of currency fluctuations by engaging in
foreign currency transactions which could expose us to substantial risk of loss.
Our management has limited experience in managing international transactions and
have not yet formulated a strategy to protect us against currency fluctuations.
There can be no assurance that fluctuations in foreign currency exchange rates
will not have a significant adverse impact upon our future operating results.

The source of the factual data in this registration statement was provided by
Mr. Raja S. Tuli, our founder, Chairman of the Board of Directors

      The information which is set forth in this registration statement was
obtained, in large part, from Mr. Raja S. Tuli, our founder, Chairman of the
Board of Directors and one of our directors. 300,000 shares of our common stock
owned by Mr. Raja S. Tuli will be registered as a result of this registration,
and he will benefit substantially from this registration of our securities. This
information necessarily incorporates significant assumptions as well as factual
matters and is believed by Mr. Tuli to be accurate.

Conflicts may exist with certain of our officers and directors

      There are several conflicts associated with our officers and directors.
These conflicts include, engaging in other businesses similar or dissimilar to
ours, allocating their time and services between us and the other entities with
which they are involved.

      Since 1993, one of our directors, Mr. Raja S. Tuli, President, has served
as the President, Chief Executive Officer and Director of the Widecom Group,
Inc. Widecom designs and manufactures "wide format office equipment" which
transmits, receives, prints, copies and archives wide format documents. Mr. Tuli
is required to spend a majority of his time for Widecom. Mr. Raja S. Tuli does
not intend to spend more than ten (10%) percent of his total working time
working for us.

      Mr. Norman Docteroff is our President, Chief Executive Officer. His wife,
Corina Docteroff, is the owner of Solutions Plus, Inc., the company with which
we have entered into an agreement to market and sell the Slimfax. Mr. Docteroff
has entered into an employment agreement with Solutions Plus, Inc. which
provides for Mr. Docteroff to receive a salary and commissions for sales. Our
employment agreement with Mr. Docteroff's permits him to engage in other
activities. However, he is required to devote a minimum of 30 hours of work per
week to us.

      The law firm of Mintz & Fraade, P.C. has been retained as our legal
counsel. Counsel owns 15,000 shares of our common stock which it purchased in
our private offering of March, 1999, at a purchase price of $.10 per share.

Our right to issue preferred stock may facilitate management entrenchment


                                       9


      Our board has the right to issue up to 2,000,000 shares of preferred stock
and to determine the rights, price, preferences, privileges, and restrictions
including voting rights of these shares without the approval of our
stockholders. Any issuance of preferred shares could be used by our current
management to delay, defer or prevent a change in management, which may not be
in the best interests of holders of our common stock. We have no present plans
to issue any shares of preferred stock.

We are dependent upon manufacturers and establishing relationships with third
parties, which could result in our inability to manufacture and market our
products.

      Although we will initially manufacture the Slimfax and other products we
may develop, we do not intend to conduct manufacturing operations on a
continuing basis and will be dependent upon independent third parties to
manufacture and ship our products. We expect to continue to be dependent upon
such manufacturers for the foreseeable future. These manufacturers will be
responsible for timely and cost-effective manufacturing which may affect our
ability to cost-effectively compete with other similar products. Therefore, we
are dependent upon the continued viability and financial stability of these
manufacturers. In addition, these third party manufacturers are expected to
produce our products to certain specifications supplied by us, however, there
can be no assurance that these instructions will be followed by the
manufacturers. The failure to produce a product in accordance with our specific
instructions and at a certain minimum level of quality could have a material
adverse impact upon the results of our operations.

      We have entered into one and intend to enter into additional agreements
with third parties to sell our products on the retail market and we expect a
substantial amount of our revenues will be derived from the sale of our products
through these third parties. We are, therefore, dependent upon the continued
viability and financial stability of these resellers. We are also dependent upon
the resellers who generally offer products of several different companies,
including, in some cases, products which will be competitive with our products.
There can be no assurance that the resellers will purchase our products or
provide such products with adequate levels of support. The entire loss of, or a
significant reduction in sales volume to any of these resellers would have a
material adverse effect upon our results of operations.

Some of our statements refer to the future, which may prove to be inaccurate

      Certain statements in this prospectus discuss future expectations and
plans which are considered forward-looking statements as defined by section
27(a) of the Securities Act of 1933, section 21(e) of the Securities Exchange
Act of 1934, and as the term has been defined in the Private Securities
Litigation Reform Act of 1995. Sentences which incorporate words such as
"believes," "intends," "expects," "predicts," "may," "will," "should,"
"contemplates," "anticipates," or similar statements are based on our beliefs
and expectations using the most current information available to us. However,
these statements involve risks and uncertainties and are subject to change at
any time which can cause actual results to differ materially from the results
discussed in such statements.


                                       10


                                 USE OF PROCEEDS

      We will not receive any proceeds from the sale of shares of our common
stock by selling stockholders. We have agreed to pay the professional fees and
expenses related to this registration statement, which we estimate to be
approximately $50,000.

                                 CAPITALIZATION

      In view of the fact that Docuport Delaware was formed on March 24, 1999
and we did not commence operations through the Delaware corporation until after
March 31, 1999, the following table sets forth, as of March 31, 1999, on an
unaudited basis, the capitalization for our Canadian subsidiary (expressed in
U.S. dollars). It does not reflect the sale of 700,000 shares of common stock at
$0.10 per share pursuant to an offering commenced in March, 1999 which closed in
April, 1999 or the sale of 435,000 shares at $2.00 per share of common stock in
April, 1999.

                                                   March 31, 1999
                                                   --------------
Liabilities:

Current Liabilities                                    $759,003

Stockholders' Deficiency:

Common Stock, $.001 par value                               $73

Total Stockholders' Deficiency(1)                     $(698,859)

Total Liabilities and Stockholders' Equity              $60,144

                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS

      We are in a developmental stage and have not generated any revenues as of
the date of this prospectus. All of our activities, since our inception, have
been devoted to the development of the Slimfax and preparation for its
introduction into the marketplace and the raising of operating capital through
the solicitation of funds in private offerings.

      The following discussion should be read in conjunction with the financial
statements and the notes to those statements which appear elsewhere in this
prospectus. The following discussion contains forward looking statements which
reflect our plans, estimates and beliefs. Our actual results could differ
materially from those discussed in the forward-looking statements. Factors

- ----------

      (1) Amounts indicated do not include shares of our common stock underlying
each common stock purchase warrant held by investors in the 1996 private
offering.


                                       11


which could cause or contribute to such differences include, but are not limited
to, those discussed below and elsewhere in this prospectus.

OVERVIEW

      We are a development stage company, principally involved in the planning,
design and development of our two products, the "Slimfax" and "Pen-Sized
Scanner". We are currently developing our Slimfax and Pen-Sized Scanner products
and anticipate beginning the initial start-up activities for manufacturing,
marketing and sale for these products within the next twelve months.

      Our business focuses on creating portable computer peripherals for the
highly-mobile professional. We believe that our initial product, the Slimfax is
the smallest multifunctional scanner, printer, copier and fax machine available
in the market; and, as a result, ideally positioned as a portable tool for
mobile executives. The second product, a Pen-Sized Scanner, could be useful to
anyone who desires a portable memory device, which permits scanning and storage
of information, until downloaded or transmitted into a personal computer.

      Although we have not begun commercially manufacturing our products and we
have not derived any revenue to date, we have manufactured small quantities for
beta site testing. We expect to have the Slimfax in production, and generating
revenue by the last quarter of this year. We will shortly begin to recruit
management level employees as well as salesmen. The extent of our hiring will
depend upon whether we manufacture the Slimfax or subcontract its manufacture to
third parties.

GOVERNMENT SPONSORED PROGRAMS

      To date, a portion of our financing has been derived from research and
development grants and reimbursements from the Canadian government. Government
sponsored programs are designed to encourage and support the development and
exploitation of new technologies by providing partial reimbursement to Canadian
businesses for expenses incurred in connection with research and development
activities.

      Companies seeking reimbursement must submit applications verifying the
amounts and nature of research and development expenditures incurred for audit
by the Canadian government. Although the Canadian government has reimbursed us
for substantially all amounts requested in each of our filings, it is not
uncommon for the government to significantly reduce the amount claimed for
reimbursement.

      We anticipate that financing derived from research and development grants
and reimbursements will account for a decreasing portion of our liquid capital
reserves.

IMPACT OF CURRENCY EXCHANGE RATES

      We have conducted a substantial number of transactions in foreign
currency, primarily the Canadian dollar and, to a lesser extent, the Indian
rupee. Fluctuations in the exchange rates between the United States dollar and
the Canadian dollar or Indian rupee, could have an adverse effect upon our
operating results in the future. We may seek to limit our exposure to the risk
of currency


                                       12


fluctuations by engaging in foreign currency transactions which could expose us
to substantial risk of loss. Our management has limited experience in managing
international transactions and have not yet formulated a strategy to protect us
against currency fluctuations. There can be no assurance that fluctuations in
foreign currency exchange rates will not have a significant impact upon our
future operating results.

RESULTS OF OPERATIONS

      The following table sets forth the percentage of net loss represented by
certain line items in the statement of operations:

                                           1998       1997
Expenses
           Salaries & Subcontractors       19%         43%
           Materials                       11%         21%
           Foreign exchange loss           21%         10%
           Financing Fees                   2%         16%
           Interest on long term debt      37%         19%
           R & D tax credits               (9%)       (29%)
           Grants & Interest               (0%)        (2%)

Net loss for the year                     100%        100%

YEAR ENDING DECEMBER 31, 1998 COMPARED TO YEAR ENDING DECEMBER 31, 1997

Operating Expenses: Operating expenses consist primarily of salaries of research
and development engineers, subcontractors in the prototyping and development
process, material purchases, interest on long term debt and financing fees.
Operating expenses net of R&D tax credits, grants and interest, decreased from
$423,343 for the year ending December 31, 1997 to $170,074 for the year ending
December 31, 1998. The decrease in operating expenses was because we reached the
final stages of development for our Slim Fax product. As overall operating
expenses decreased in 1998, the interest on the long-term debt (from the 1996
private offering) decreased by 6% from $61,373 in 1997 to $57,570 in 1998, but
resulted in 37% of the net loss for the year ending December 31, 1998 compared
to 19% for the year ending December 31, 1997. Financing fees for 1998 were 2%
while they were 16% of the net loss of 1997, as no new financing was done in
1998. Salaries and subcontractors accounted for 19% of the net loss for 1998,
compared to 43% for 1997, which was a 79% decrease from $140,558 in 1997 to
$29,552 in 1998.

Government Grants and Reimbursements: Referred to as research and development
tax credits, these grants are available as reimbursements to us, until the stage
when we reach profitability and have


                                       13


taxes payable to the Canadian government. At the stage when we have taxes
payable, these grants are applied to the taxes. The R&D tax credits are
available to us as a percentage of research and development expenses, and are
not available for expenses related to currency exchange losses, financing fees,
or other expenses outside of Canada. The R&D tax credits reduced in 1998 by 86%
to $13,482 from $93,897 for the year ending December 31, 1997.

INTERIM ENDING MARCH 31, 1999 COMPARED TO INTERIM ENDING MARCH 31, 1998

Operating Expenses: Operating expenses consist primarily of salaries of research
and development engineers, subcontractors in the prototyping and development
process, material purchases, interest on long term debt and financing fees.
Operating expenses net of R&D tax credits, grants and interest, increased from
$33,559 for the year ending March 31, 1998 to $83,599 for the year ending March
31, 1999. The increase in operating expenses was because we reached the final
stages of development for our SlimFax product. As overall operating expenses
increased in 1999, the interest on the long-term debt (from the 1996 private
offering) increased by 2% from $14,376 in 1998 to $14,656 in 1999, but resulted
in 80% of the net loss for the quarter ending March 31, 1999 compared to 38% for
the quarter ending March 31, 1998. Salaries and subcontractors accounted for 52%
of the net loss for 1999, compared to 51% for 1998, which was a 68% increase
from $11,282 in 1998 to $35,254 in 1999.

LIQUIDITY AND CAPITAL RESOURCES

      Historically, we have satisfied our working capital requirements
principally through the issuance of debt and equity securities and government
sponsored research and development grants and reimbursement. As of March 31,
1999 we had working capital of negative $705,649, as compared to negative
$621,438 on December 31, 1998 and negative $500,610 on December 31, 1997.

      In July 1996 we conducted a private offering pursuant to Rule 504 of the
Securities Act of 1933, as amended. The offering raised $575,000 which we used
as working capital and to assist research and development of our products. Each
investor in the 1996 private offering purchased a unit (or a fractional unit)
valued at $50,000. Each unit consisted of the following: (a) a $50,000
promissory note bearing 10% interest per year and maturing upon the earlier of
two years from issuance or the effective date of an initial public offering; (b)
10,000 shares of common stock; and (c) 10,000 common stock purchase warrants.
Upon a resolution of our Board of Directors, passed on March 24, 1999, all
shares of common stock and warrants in the Canadian subsidiary were exchanged
for shares in the Delaware parent (the "Exchange"). The ratio of the Exchange
was three (3) shares or warrants in the parent for every two (2) shares or
warrants in the Canadian subsidiary.

      In February, 1999 we offered an extension agreement to the investors of
the 1996 offering which extended the due date of the Promissory Notes which were
part of the 1996 private offering. Sixteen of the 18 investors agreed to the
extension. As compensation to the investors who agreed to the extension, we: (A)
issued additional warrants equal to the number of the warrants held (as adjusted
upon the Exchange) with an exercise price of $0.10 per share and (B) the
exercise price for the warrants originally issued in connection with the 1996
private offering was reduced from $1.67 (as adjusted) to $0.10. The extension
agreement extended the due date for the Promissory Notes


                                       14


until the earlier to occur of either (a) August 1, 2000; or (b) the raising an
aggregate of $5,000,000 in financing.

      In March, 1999 we commenced a second private offering, which closeed in
April, 1999 raising $70,000. The offering consisted of shares of its common
stock, at a purchase price of $0.10 per share. These shares are restricted and
cannot be transferred until the earlier to occur of one year after purchase or
registration of the shares with the SEC.

      In April, 1999 we completed a private offering, raising $870,000. The
offering consisted of shares of our common stock, at a purchase price of $2.00
per share.

      We believe, based upon our currently proposed plans and assumptions
relating to our operations (including, assumptions with respect to the progress
of research and development and the costs associated with production, marketing
and sale of out products), that our current cash position and projected cash
from operations will be sufficient to satisfy our contemplated cash requirements
for the next six to nine months following the filing of this registration. How
quickly we will need additional financing will depend upon how we determine it
is in our best interest to manufacture and market the Slimfax. If we proceed
with production ourselves, we will need additional financing sooner than if we
contract manufacture of the Slimfax to third parties. Such a determination will
also affect the number of employees we anticipate hiring in the next 12 months.
If we do not manufacture the Slimfax ourselves, we anticipate the need for an
additional 30-40 employees, including salesmen, management, engineers and other
skilled employees within the next 12 months. If we manufacture the Slimfax
ourselves, we will require additional employees, the number of which is
uncertain and will be dependant upon the extent of our manufacturing activities.
If our plans change, or our assumptions change or prove to be incorrect, or if
projected cash flow proves to be insufficient to fund operations (due to
unanticipated expenses, delays, or other problems), we could be required to seek
additional financing sooner than anticipated. We have no current arrangements to
obtain, or sources of, additional financing and it is not anticipated that
existing stockholders will provide any portion of our future financing
requirements. There can be no assurance that additional financing will be
available to us, when needed, on commercially reasonable terms, or at all.

      Under SFAS No. 133, "Accounting for Derivatives Instruments and Hedging
Activities" a company is required to record derivatives on the balance sheet as
assets or liabilities, measured at fair market value. Gains or losses resulting
from changes in the values of those derivatives are accounted for depending on
the use of the derivative and whether it qualifies for hedge accounting. The key
criterion for hedge accounting is that the hedging relationship must be highly
effective in achieving offsetting changes in fair value or cash flows. SFAS No.
133 is effective for fiscal years beginning after June 15, 1999. Management
believes that the adoption of SFAS No. 133 will have no material effect on its
financial statements.

      SOP 98-5, "Reporting on the Costs of Start-Up Activities," requires that
the costs of start-up activities, including organization costs, be expensed as
incurred. This statement is effective for fiscal years beginning after June 15,
1999. Management believes that the adoption of SOP 98-5 will have no material
effect on its financial statements.

      The Year 2000 problem is the result of computer programs being written
using two digits (rather than four) to define the applicable years. We are a
development stage company which


                                       15


relies heavily upon computer technologies to operate our business. We believe,
that due to the widespread nature of potential Year 2000 issues, any contingency
planning process is an ongoing one which will require further modifications as
we obtains additional information regarding (1) the Company's internal systems
and (2) the status of third party Year 2000 readiness. Contingency planning for
possible Year 2000 disruptions will continue to be defined, improved and
implemented. The following discussion of the implications of the Year 2000
problem for us contains numerous forward-looking statements based upon
inherently uncertain information.

      We place a high degree of reliance on our computer systems and those of
third parties, such as customers, product suppliers and computer hardware and
commercial software suppliers. We believe that our products, computer systems
and software are fully year 2000 compliant. However, it is possible that certain
of our computer systems or product suppliers or our customers many not accept
input of, store, manipulate and output dates in the year 2000 or thereafter
without error or interruption. We are investigating our current suppliers'
progress in identifying and addressing problems which their computer systems
will face in correctly processing date information as the year 2000 approaches.
Although we are assessing the readiness of these third parties and preparing
contingency plans, there can be no assurance that the failure of these third
parties to modify their systems in advance of December 31, 1999, would not have
a material adverse effect upon us.

      If problems are discovered with our current suppliers which cannot be
remedied we intend to seek alternative suppliers who are fully year 2000
compliant. We may, however, be required to make significant expenditures to
address or remedy any year 2000 problems of our vendors which are not identified
in advance, or to satisfy liabilities to which we may become subject as a result
of such problems. An interruption of the our ability to conduct business due to
a Year 2000 readiness problem could have a material adverse effect upon us.

                             DESCRIPTION OF BUSINESS

      Our Canadian subsidiary was incorporated under the laws of Canada in
February, 1992, under the name SlimFax, Inc. In 1996 the Canadian company
changed its name to Docuport, Inc. The Canadian corporation was founded by its
current President and Chief Financial Officer, Mr. Raja S. Tuli. Mr. Raja S.
Tuli is also our Chairman of the Board of Directors. When Docuport Delaware was
incorporated on March 24, 1999 the Board of Directors agreed to transfer
5,567,500 shares of common stock together with the equivalent rights to purchase
common stock pursuant to warrants owned, to the shareholders of our Canadian
subsidiary in exchange for 3,711,667 common shares and any warrants held of the
Canadian subsidiary. This constituted all the issued and outstanding shares of
the Canadian company.

Proposed Business

      We intend to become a leading developer of portable computer peripheral
equipment. Following five years of research and development, we have developed
and intend to market a patented, "portable" multi functional office machine
called the Slimfax, which we believe is the first product of its kind. The
Slimfax is a combination:

      (1) full page fax machine;


                                       16


      (2) full page scanner;

      (3) full page printer,

      (4) full page copier; and

      (5) fax/data modem,

with dimensions of 12.5" x 3" x 1.24". Full page means 8.5 inches x any length.
The Slimfax weighs approximately 2.1 lbs. It utilizes a power supply consisting
of either a DC connector which conveniently plugs into any electrical outlet; a
rechargeable Nickel Metal Hydride battery and an AC adapter to plug into the
cigarette lighter of a car or boat. We know of no other product currently on the
market which possesses these multifunctional capabilities in this size and
weight.

      After five years of research and development, a compact, portable design
was created, for which a United States patent was granted. This patent is based
upon a single roller concept placing a scan head which reads the information fed
into the Slimfax on one side of the roller and print head on the other side of
the roller. A second patent has been refiled after being inadvertently deemed
abandoned by the United States Patent and Trademark Office and the company has
re-submitted such patent. This second patent protects our technology, based upon
support arms allowing documents fed through the Slimfax to pass through the
mechanism unobstructed, which is critical in such a compact design. Three
additional patents are pending for new designs for the Slimfax and related
technologies.

      The research and development expenditures for our fiscal years ending
December 31, 1997 and 1998 were $209,800 and $46,440 respectively.

      The Slimfax can be used to create a portable office through its ability to
be used with both conventional telephone land lines or in conjunction with
cellular phones, allowing the Slimfax to be used in any location where a
telephone connection can be established.

Product Features

      The features of the Slimfax are as follows:

Direct Thermal. The Slimfax incorporates a direct thermal printing technology.
We believe that the direct thermal method provides excellent print quality,
removing the need to carry ribbons and cartridges used in larger printers and
allowing for a very compact and portable design.

Facsimile Machine (Fax). Portable Fax Machines began entering the market in 1993
and 1994. The Slimfax is a full featured, full size (8.5 inches x any length)
fax machine which we believe is the smallest fax machine currently available on
the market. The Slimfax is capable of printing at a speed of 9600 bps (bits per
second) on 8.5 inch sheets or rolled paper and has three modes of resolution
(standard, fine and super fine). If the Slimfax is connected to a telephone line
or cellular phone it can transmit and receive hard copy facsimiles. We believe
that because of Slimfax's patented single roller design, the Slimfax is smaller,
more portable and less expensive than those of the competition. The competitor's
models include Mitsubishi F- 15, Ricoh's "World's smallest fax machine" and NEC
i300. The NEC i300 can only be used with NEC cellular telephones and is very
costly. Sending a


                                       17


fax with the Slimfax is done in the same manner as using a stand-alone fax
machine, by inputting the media or file and pressing the corresponding buttons
on the keypad. Limited distribution and high retail costs have prevented the
anticipated growth of portable fax machines. We believe that the current
products in this market will not challenge the Slimfax due to the size, price
and weight of the Slimfax.

Printer. The Slimfax can print full size documents. It can print letters,
spreadsheets, and drawings at a resolution of up to 200 x 400 dpi (dots per
inch) and at a speed of up to two pages-per-minute. Since the Slimfax uses
direct-thermal technology, it removes the necessity of cartridges and ribbons.
There are two general categories in the portable printer market: (A) portable
printers, which are used as either a desktop or a portable printer and (B)
compact portable printers, which are used by mobile business people and
professionals. Portable printers usually weigh between two to seven pounds and
we believe that the only two manufacturers of compact portable printers weighing
less than two (2) pounds are Pentax Technologies and Citizen-America; however,
these are only single function products and, therefore, we believe they are not
directly competitive.

      The method used by printers currently include ink jet, bubble jet, thermal
fusion, thermal ribbon and direct thermal technology. Both the ink jet and the
bubble jet require ink cartridges for printing. We believe that the direct
thermal method, which is utilized by the Slimfax as well as certain of its
competitors, permits a compact design and provides excellent print qualities
without requiring the user of the Slimfax to maintain a supply of ribbons or
cartridges.

Scanner. Portable scanners are relatively new to the marketplace. The Slimfax is
a full size, high resolution contact scanner with a resolution of 200 x 400 dpi,
capable of scanning up to two pages-per-minute. Using the Slimfax to scan media
into a computer for recall and printing at the user's convenience removes the
need to carry documents and paperwork. The first company to enter the portable
scanner market was Logitech, with the ScanMan. However, since the ScanMan can't
scan a full page at one time, we believe that the ScanMan will not be
competitive with the Slimfax.

Copier. The Slimfax has a single roller design which allows full size documents
to be scanned and printed simultaneously. This enables the Slimfax to act as a
copier, with an optical resolution of 200 x 400 dpi and print resolution of 200
x 400 dpi. Copies can be made at a speed of two pages-per-minute. At the present
time there are no portable copiers on the market. Xerox attempted to introduce a
portable copier but we believe that this product did not gain acceptance in the
market place. We believe that, since our competitors copiers, while small, are
not easily transportable and certainly not of such size which would merit being
called portable, they will not be competitive with the Slimfax.

Fax Card and Modem for Laptops and Notebooks. The Slimfax can act not only as a
hard copy fax machine, but also utilizes a fax card enabling the user to fax
documents directly from a word processor. Laptops and notebook computers have
facsimile transmission capabilities as part of their software packages, however,
we believe that owners of laptops and notebook computers who only have need for
facsimile transmissions will most likely not purchase the multi-function
Slimfax. The prices of fax cards have generally decreased, even though the cost
of fax cards for notebook computers is still high due to the miniaturization
required. We believe that, because of the high costs, these products are not
competitive with the Slimfax for end users who desire multiple functions in
conjunction with their computer.


                                       18


Power Supply.  The Slimfax's power is supplied by one of three means:

      (i) a DC connector which conveniently plugs into any electrical outlet;

      (ii) a rechargeable Nickel Metal Hydride battery; or

      (iii) an AC adapter which plugs into the cigarette lighter of a car or
      boat.

Customer Base.

      We believe that potential customers of the Slimfax will be end users, who
are individuals purchasing the Slimfax for personal use and companies which will
purchase the Slimfax for distribution to employees who travel as a necessary
element of their employment.

      End users will be: (A) professionals who travel for business purposes; (B)
individuals who own laptop, notebook, or subnotebook computers; (C) anyone who
owns or plans to purchase a portable peripherals for mobile computing; (D)
anyone who requires hard copy facsimile transmissions from remote locations; (E)
anyone requiring a transportable scanner and (F) anyone needing more space at
their desk.

      We believe that our major customers will be (A) Distributors; (B)
Licensees; (C) System Integrators and (D) Value Added Resellers who will market
and sell to end users, such as computer and technology retail stores.

Product Strategy

      We intend to create unique packaging for the Slimfax in order to create
quick market awareness and product recognition. This will be part of
multi-faceted marketing campaign designed to introduce the Slimfax to the retail
market. We believe the easy to use design of the Slimfax will be a critical
factor in creating quick market acceptance. An example of the Slimfax's user
friendly design is the use of thermal technology which eliminates the need for
toners and cartridges. We believe that thermal technology is as good or better
than ink jet or laser technology, both which require the use of either toners or
cartridges. We believe the Slimfax will have a competitive advantage based upon
its multiple functions, its size/portability and high quality at an affordable
price. We believe that the Slimfax is very practical and efficient, which is a
necessity in today's mobile product environment.

Pricing Strategy.

      We believe that the Slimfax is the first product of its kind to be
introduced to the portable computer market. Therefore, pricing of the Slimfax
will not be influenced by the retail market for multi-function products, but
upon the retail market for portable single use products of equal size and target
customer base. We intend to compete with the price of other similar products
which are currently in the market which are not portable. Our initial retail
pricing of the Slimfax will be approximately $299.00 with an anticipated
reduction to $200.00 one year after the commencement of sales to the public.

Distribution Strategies.


                                       19


      Although we are reviewing the advantages of distribution by a large
company with the experience and contacts necessary to handle the introduction of
the Slimfax to the market, we have not entered into any agreements as of the
date of this registration statement.

      Retail channels of products similar to the Slimfax include: (i) Mail
order/catalog, superstore/computer/office equipment dealers, traditional
computer store and warehouse/club for multifunctional products; (ii) mail
order/catalog, superstore/office/computer specialty store, traditional computer
store, mass merchants and retail stores for personal sheet-federal scanners and
(iii) mail order/catalog, superstores/computer office stores, specialty store,
traditional computer store, mass merchants and retail stores for portable
printers. Peripheral Magazine performed an end user study which identified the
mail/order catalog and both computer and office equipment superstores as the two
prime sales channels for products similar to the Slimfax.

      We intend to sell the Slimfax through the following distribution channels:

      Direct Marketing. We intend to mail directly to companies which fit a
certain criteria information with respect to Slimfax, followed by telephone and
local demonstrations. Our main purpose for direct sales will be to expeditiously
start the first year sales so there is revenue being generated even if takes the
first year or so to develop the distribution network. We intend to shift the
primary focus towards training dealers on how to sell. We believes that it is
important to constantly have a small internal direct sales force because it will
keep us in touch with end users and gives us better control in directing our
retail dealer base.

      Dealers/Distributors. We intend to target distributors which already carry
scanners, copiers, facsimiles, printers, and multifunctional devices. Examples
of the some of the most common distributors for competitive products, include
Ingram Micro, Miresel, TechData and Globelle. We believe that by targeting such
respected names, it will facilitate distribution resulting in early retail
shelf-space.

      Retail. We intend to focus on retail channels targeting knowledgeable,
well educated, middle to high income, technically knowledgeable professionals
who travel frequently and need to remain in contact with both clients and their
base offices. We believe that these individuals already own or use portable
computers and will have a use for multi-purpose peripheral equipment such as the
Slimfax.

      OEM Channels. We believe that, in the long term, this distribution channel
will be extremely important to us. We desire to sell rights to the Slimfax to
established companies with immediate market recognition which can private label,
i.e., put their own name on the Slimfax. The companies to be targeted will be
manufacturers of computer equipment such as Hewlett Packard, Visoneer,
Pentax-Technologies. We have entered into a non-binding letter of intent with
Pentax Technologies for the purpose of distributing the Slimfax in this manner.
Pentax Technologies intends to privately label the Slimfax pursuant to this
letter of intent.

      System Integrators. There are many companies across North America which
sell mobile office solutions. They usually package a special design brief case
which includes a notebook computer, portable printer, and, on occasion, a
sheetfed or hand fed scanner and cellular phone. These are then sold as packages
in volume to governments, real estate companies, insurance companies, and other
business which involve significant travel as a complete mobile office solution.


                                       20


We believe that companies will have a great interest in the Slimfax since it
will offer them greater mobility, a small product size, and more features
without an increase in cost.

      Value Added Reseller's. These companies are responsible for marketing and
selling the package which System Integrators design for end users. We intend to
utilize value added resellers in our second year of operations. We intend to
launch the Slimfax with extensive publicity in several major cities together
with large volume mailings to certain target publications. We intend to place
descriptive articles announcing the introduction of the Slimfax in a large
number of newspapers and trade magazines in the hopes of alleviating the high
cost of private advertising.

      Internet - World Wide Web. Since the Internet has a rapidly increasing
number of users, we intend to design and maintain a webpage for use as a
marketing tool in an attempt to capitalize on the rapidly growing information
highway.

Future Products

      We intend to improve the features of the Slimfax by developing and
producing new features such as infrared data association, color printing,
increased printing, copying, scanning, faxing speed and increased resolution. We
believe that these features are essential to maintain what we believe is the
Slimfax's position ahead of present and future competitors.

      Additionally, we are in the process of developing a portable pen-size
scanner. The Pen-Size Scanner is 8.5 inches in length with an outside diameter
of a 1/4" and weighs 2.5 ounces, which enables individuals to keep the unit in
their possession at all times. The Pen-Size Scanner has a color contact-sensor.
It utilizes a power supply of a rechargeable lithium battery which, when fully
charged, is capable of 100 scans. The Pen-Size Scanner has a memory of up to 100
image or text files. Scanning is performed by holding the unit in ones' hand,
across the entire 8.5 inch width of a page and manually pulling the scanner down
the entire length of the page over the image to be scanned which results in an
8.5 x 11 image. In view of the Pen-Sized Scanner's portability, it is ideal for
remote locations.

      The Pen-Size Scanner allows the user to save the scanned document, which
can then be downloaded to any computer for viewing or merging into word
processing programs, spreadsheets or graphics design applications such as MS
Word, Excel, Photoshop and Coral Draw.

      We intend to complete development of the Pen-Sized Scanner and to
manufacture a prototype within the next 60 days. Within six months following the
initial production, we intend to begin production and beta testing of the
Pen-Sized Scanner.

      We are also researching and in the process of developing a Second
Generation Slimfax. Unlike current industry standards which incorporate a
parallel scan-head design for use in personal-sheetfed scanning products, the
Second Generation Slimfax will utilize a traversing scan head and print head.
This traversing scan head and print head will result in the Second Generation
Slimfax being smaller than the Slimfax we initially intend to introduce into the
market. Moreover, we contemplate that the Second Generation Slimfax will be
produced at a lower cost than the Slimfax. We have applied for a U.S. patent to
protect our proprietary rights to this technology. This new


                                       21


product will be marketed as a single unit or in a modular format for single
functions such as a fax, printer or scanner.

      We will initially manufacture the Slimfax ourselves. However, when demand
for the Slimfax increases, we intend to enter into agreements to have the
Slimfax manufactured abroad. Once these contracts are entered into, we will no
longer manufacture the Slimfax.

Dividend Policy

      To date, we have not paid dividends on our common stock and at the present
time, we intend to retain earnings, if any, for our development and expansion.
There can be no assurance that we will have enough earnings to pay any dividends
on our common stock. Even if we have sufficient earnings, we are not obligated
to declare dividends on our common stock. Our board has sole and absolute
discretion whether to declare any cash or stock dividends. This decision will be
based upon the following:

      o   earnings;
      o   capital requirements;
      o   our financial position;
      o   general economic conditions; and
      o   other factors the board may consider.

      It is also possible that the terms of any future debt financing may
restrict the payment of dividends.

Employees

      We currently employ six full time employees consisting of four engineers,
one technician and one computer scientist. In addition, Mr. Norman Docteroff has
signed an employment agreement with us which requires him to work a minimum of
30 hours per week for us. Mr. Raja S. Tuli has orally agreed to spend 10%
percent of his time working for us.

Offices

      Our executive offices are currently located at 1155 Rene Levesque West,
Suite 3500, P.O.Box 60, Montreal, PQ, H3B 3T6, Canada. The offices are provided
by Technologie Novimage, a research and development company, of which Raja S.
Tuli, who is our founder, Chairman of the Board of Directors, owns 10% of the
issued and outstanding common stock. We are not charged for use of this office
space. We are currently examining a proposal for additional office space at 1000
St-Antoine Street, Suite 700, Montreal, Canada for use as an assembly and
manufacturing site and for additional office space for a term of one year. The
premises is comprised of 2,490 square feet for a minimum lease price of $9,960
per year.

      In addition we utilize 2000 square feet of office space provided by
Solutions Plus, Inc., at no cost pursuant to our Marketing and Sales Agreement,
for our United States operations. These offices are located at 81 Two Bridges
Road, Fairfield, New Jersey, 07004. If the space provided by


                                       22


Solutions Plus, Inc., at this location is insufficient for our needs, as
determined by our board and Solutions Plus, Inc., we will enter into a lease for
office space which meets our requirements.

                                   MANAGEMENT

Executive Officers and Directors

      The following table sets forth the names and ages of the members of our
board, our executive officers and the positions they each hold.

Name                              Age               Position
- ----                              ---               --------

Norman Docteroff                   65          President and
                                               Chief Executive Officer

Raja S. Tuli                       33          Chairman of the Board
                                               of Directors

Madan G. Singh                     53          Director

Lakhbir Tuli                       61          Director

Melvin Yablon                      69          Director

      Mr. Norman Docteroff has been our President and Chief Executive Officer
since April 15, 1999, pursuant to a three year employment agreement. In 1994,
Mr. Docteroff founded and is currently President and a Director of Solutions
Plus, Inc., which is wholly owned by his wife Corina Docteroff. Solutions Plus,
Inc. specializes in assisting small companies to market and sell their products.
From 1989 to 1994, Mr. Docteroff was employed under a five year management
contract by Gemini Industries, Inc., a business he and an associate started in
1968. Gemini Industries, Inc., manufactured various audio and video accessories.
In 1986, Mr. Docteroff and his associate sold 75% of the business. The remaining
25% was sold in 1989. From 1962 to 1968, Mr. Docteroff was the national sales
manager of Manhattan Industries, a major consumer products company. From 1957 to
1961, Mr. Docteroff owned and operated hardware departments in chain department
stores, which were sold to Modells Department Stores. Mr. Docteroff is a
director of several private companies and of Xceed Corp., a public company
engaged in providing companies with marketing, sales and interactive and network
services. These services focus on the expanding use of the Internet as a retail
sales medium. Xceed trades on the Nasdaq National Market System.

      Raja S. Tuli, our founder, had been our President, Chief Executive Officer
from the inception of our Canadian subsidiary until April 5, 1999. Since our
hiring of a new President and Chief Executive Officer in April 1999, Mr. Tuli
has been serving as our Chairman of the Board of Directors. From 1990 to the
present, Mr. Tuli has been President, Chief Executive Officer and a Director of
WideCom Group, Inc. From 1990 to 1993, Mr. Tuli was also Treasurer of WideCom
Group, Inc. From 1987 to 1990 Mr. Tuli was President of CACE Ltd. a family-owned


                                       23


architectural/construction business. Mr. Tuli received a Bachelor of Science
degree in Computer Engineering in 1988 from the University of Alberta.

      Madan G. Singh, an uncle of Raja S. Tuli, has been one of our directors
since the inception of our Canadian subsidiary. He received doctorate degrees
from Cambridge University (England), Toulouse (France) and the University of
Waterloo (Canada). Dr. Singh has a B.S. from Exeter University, and a M.S. from
Manchester University. Dr. Singh has been the Chairman of the Computer
Department and Chairman of Control Engineering at the University of Manchester
Institute of Science and Technology in Manchester, England since 1979. He was
head of the Post Graduate Department of the University of Manchester from 1981 -
1983 and from 1985 to 1987. In February 1994, he was made a "Chavalier dans
l'ordre des Palmes Academiques" (a French academic honor) by a decree signed by
the Prime Minister of France. Dr. Singh edited the ten volume "Encyclopedia of
Systems and Control", coordinated the publication of eight Concise Encyclopedias
(each on a different matter), authored or co-authorized eight books and over 170
scientific articles and edited or co-edited ten additional books.

      Lakhbir Tuli, father of Raja and Suneet Tuli (brother of Raja S. Tuli and
one of our principal shareholders), has been one of our directors since the
inception of our Canadian subsidiary From 1993 to the present, Mr. Tuli has been
president of Widecom Fax and Plotters, Inc. From 1990 to the present, Mr. Tuli
has been a consultant to WideCom Group, Inc. Mr. Tuli received a M.S.C. science
degree in Civil Engineering from Punjab University in 1961.

      Melvin Yablon has been one of our directors since July __, 1999. From 1990
until 1998, Mr. Yablon was the president and sole shareholder of North America
Intercon, Ltd., a company engaged in importing goods for sale. From 1977 to the
present, Mr. Yablon has been the president and sole shareholder of First
Adjusters, Inc., an insurance adjusting firm.

      All of the our directors will serve until the next annual stockholders'
meeting when their successors will be elected and qualify. Officers are elected
at the meeting of the Board following the annual stockholders' meeting. None of
the current officers or directors are required or expected to devote all of
their time to our business.

      Mr. Raja S. Tuli and members of his immediate family (Raja S. Tuli and
members of his immediate family are hereinafter collectively referred to as the
"Tuli family shareholders") own approximately 58% of our issued and outstanding
common stock. The Tuli family stockholders have agreed that for a period of five
years commencing April 1, 1999, our board will consist of five board members and
that two of our directors will be outside directors, who are directors whom we
do not employ. We have only one outside director as of the date of this
prospectus. We anticipate that a second outside director will soon be elected by
our shareholders other than the Tuli family stockholders. This agreement also
provides that for this five year period the Tuli family stockholders will not
have the right to participate in a vote to elect the outside directors. The
outside directors will, therefore be elected by a majority of our other
stockholders. This agreement will remain in effect for five years unless an
underwriter of a future registration of our securities requests that this be
changed. Whether or not to comply with the underwriter's request will be in the
sole and absolute discretion of the Tuli family stockholders. Even though our
outside directors will be elected by stockholders other than the Tuli family
stockholders, the Tuli family stockholders will control our management and
affairs. After the five year period, based upon their present ownership
percentage


                                       24


of our issued and outstanding common stock, the Tuli family stockholders, will
have the power to elect all of our directors.

      We will pay each of our outside directors $1,000 for each board meeting
they attend. Each outside director is also entitled to reimbursement for
reasonable expenses incurred with respect to attending each meeting.

Executive Compensation

      We have entered into a three year employment agreement with Norman
Docteroff, who is our President and Chief Executive Officer. The agreement
provides a salary in the form of options to purchase an aggregate 250,000 shares
of our common stock at an exercise price of $2.00. Each month, a pro rata share
of the options will vest; Mr. Docteroff will earn the right to purchase 6,945
options each month. On May 1, 1999, we made the first $10,000 monthly payment to
Solutions Plus, Inc. pursuant to the Marketing and Sales Agreement dated the 5th
day of April, 1999 and are obligated to make 34 additional monthly payments.
These payments will last for the duration of the three year agreement. Solutions
Plus, Inc. is owned by Corina Docteroff, wife of Mr. Docteroff, who is the
president and a director of Solutions Plus, Inc.

      We can terminate the employment of Mr. Docteroff upon death or extended
disability or for cause as defined in the employment agreement. In addition, we
may terminate his employment agreement for any reason upon 30 days' notice. If
we terminate without cause, the remaining options which have not vested will
immediately vest.

      Raja S. Tuli receives an annual salary of CN$24,000 (Canadian Dollars) in
payments of CN$2,000 per month. We do not have a written agreement with Mr. Tuli
for his employment.

Stock Option Plan

      We intend to implement a stock option plan in the near future. The purpose
of the plan will be to provide our directors, officers, key employees and
consultants with additional incentives by increasing their ownership interests.
The stock option plan, which we anticipate will incorporate both qualified and
non-qualified options, will contain terms which shall be approved by the board
and submitted to the shareholders for approval.

Indemnification of Directors and Officers

      Our certificate of incorporation contains the following provision with
respect to indemnification of our directors and officers:

      The personal liability of the directors of the Corporation is hereby
eliminated to the fullest extent permitted by the provisions of Section
102(b)(7) of the General Corporation Law of the State of Delaware, as the same
may be amended or supplemented.

      This provision does not eliminate or limit the liability of a director for
violating the following:


                                       25


            o duty of loyalty (which includes a director's obligation to refrain
from self dealing with us improperly competing with us or usurping our
opportunities);

            o failing to act in good faith;

            o engaging in intentional misconduct or knowingly violating a law;
or

            o participating in the payment of a dividend or a stock repurchase
or redemption for himself.

      This provision does not affect any director's liability under federal
securities laws or the availability of equitable remedies such as an injunction
or rescission for breach of fiduciary duty.

      We intend to purchase directors liability insurance for our officers and
directors. However, there can be no assurance that such insurance will be
available to us at commercially reasonable terms, or at all.

Certain Relationships and Transactions

      In December, 1998, we entered into a three year management and consulting
agreement with Rexon Limited, a Swiss based company. The agreement provides that
Rexon will provide us with various management, marketing, business planning an
acquisition strategies. As compensation, Rexon received 23.3% of the then issued
and outstanding shares of the common stock of the Canadian corporation. Upon the
exchange of the Canadian Corporation's shares for ours, Rexon became the
beneficial owner of approximately 1,195,000 shares of our common stock.
Subsequently, Rexon transferred 295,000 shares to Diversified Investors for
services rendered to Rexon and 616,000 shares to other third parties. In
addition, we have agreed to pay Rexon $5,000 per month for a period of two years
after we become a publicly traded company. We have not yet begun to pay Rexon
its fees.

      In April, 1999, we entered into three year non-exclusive Marketing and
Sales Agreement with Solutions Plus, Inc., which is wholly owned by Corina
Docteroff, the wife of Norman Docteroff, who, in addition to being our President
and Chief Executive Officer, is the President and a Director of Solutions Plus,
Inc. Mr. Docteroff has signed an employment agreement which requires him to work
a minimum of 30 hours per week for us. Solutions Plus, Inc. specializes in
marketing, sales and networking. The agreement requires Solutions Plus, Inc. to
market, sell and provide support services with respect to the Slimfax. In
addition, Solutions Plus, Inc. will provide the following services:

      o manage our financial records including the billing of customers, payment
of expenses such as insurance policies, leases, bills and other related
administrative matters;

      o maintain our employment records;

      o maintain account and company records in accordance with generally
accepted accounting standards; and

      o maintain an operating account for us for the deposit of funds generated
by product sales and for payment of our operating expenses.


                                       26


As part of our marketing agreement, Solutions Plus, Inc. is providing us with
space in their offices for our United States based employees such as our
accounting, sales and marketing staff. In exchange, we agreed to pay Solutions
Plus, Inc. $10,000 per month starting May 1, 1999 and continuing for the
duration of the agreement. Solutions Plus, Inc. will receive 10% of gross sales
which Solutions Plus, Inc. generates of our product, less returns. In addition,
Solutions Plus, Inc. will receive 5% of all gross sales of our product to
companies which sell the Slimfax under their own private label, less returns. We
can terminate the Marketing and Sales agreement if Solutions Plus, Inc. fails to
sell 25,000 Slimfax machines within the first twelve months after the Slimfax
becomes commercially available and an additional 125,000 Slimfax machines during
the second 12 month period after the Slimfax becomes commercially available.


                                       27


                             PRINCIPAL STOCKHOLDERS

      The following table sets forth the number of common stock owned and the
percentage of our outstanding shares of common stock as of July 9, 1999 for the
following:

      o all persons who own more than 5 percent of our outstanding common stock;

      o each officer and director;

      o officers and directors as a group.

- --------------------------------------------------------------------------------
                                               AMOUNT OF
                 NAME                          BENEFICIAL             PERCENTAGE
                                               OWNERSHIP
- --------------------------------------------------------------------------------
Raja S. Tuli
c/o Docuport, Inc.
1155 Rene Levesque West                        1,750,000                 29.15%
Suite 3500
Montreal, PQ, H3B 3T6, Canada
- --------------------------------------------------------------------------------
Suneet Tuli(1)
c/o Docuport, Inc.
1155 Rene Levesque West                          875,000                 14.57%
Suite 3500
Montreal, PQ, H3B 3T6, Canada
- --------------------------------------------------------------------------------
Lakhbir Tuli
1290 Whiteoaks Avenue
Mississauga, Ontario                             875,000                 14.57%
L5J 3C1
Canada
- --------------------------------------------------------------------------------
Norman Docteroff
81 Two Bridges Road                               27,780(2)                .46%
Fairfield, New Jersey 07005
- --------------------------------------------------------------------------------
Melvin Yablon
220 East 57th Street, Apt. 2C                     37,500(3)                .62%
New York, NY 10022
- --------------------------------------------------------------------------------
Diversified Investors Capital
Services of North America, Inc.                  704,000                 11.73%
850 Third Avenue
New York, N.Y. 10022
- --------------------------------------------------------------------------------


                                       28


- --------------------------------------------------------------------------------
Madan Singh                                         0                     0.0%
c/o Docuport, Inc.
1155 Rene Levesque West
Suite 3500
Montreal, PQ, H3B 3T6, Canada
- --------------------------------------------------------------------------------
All Officers and Directors
as a group (6 people)                           3,565,280                59.40%
- --------------------------------------------------------------------------------

- ----------
(1) Suneet Tuli is the brother of Raja S. Tuli, who is our Chairman of the Board
of Directors and the son of Lakhbir Tuli, one of our directors.

(2) Includes options to purchase shares of our common stock which were issued to
Mr. Docteroff as compensation in connection with his employment agreement to
serve as our Chief Executive Officer and a director.

(3) Amounts indicated do not include 7,500 shares of our common stock underlying
the common stock purchase warrants held by Mr. Yablon which he purchased in the
1996 private offering. Those warrants will not be exercisable until the earlier
to occur of either August 1, 2000 or the closing of a financing of $5,000,000.

      We believe that each of the persons and entities listed above have the
sole voting power with respect to the shares of common stock beneficially owned
by each of them.

      We have entered into an agreement with the following: Mr. Tuli and certain
members of his family who own our common stock, Rexon Limited and Diversified
Investors Capital Services of North America, Inc. with respect to their
ownership of our common stock and our registration of their shares. In exchange
for registering certain of their shares which are the subject of this
registration statement, Mr. Tuli and the members of his family who own shares of
our common stock may sell 300,000 shares at the rate of 100,000 shares per
quarter and Rexon Limited and Diversified Investors may each sell 75,000 shares
at the rate of 25,000 shares per quarter. The first quarter commences 90 days
following this registration statement becoming effective.

Plan of Distribution

      Prior to this registration, no public market for our securities existed. A
total of up to 1,233,333 shares may be sold pursuant to this prospectus by
certain of our stockholders. Except as we have described above, the stockholders
selling our stock have never held any position or office with us or had any
other material relationship with us. We will not receive any of the proceeds
from the sale of our common stock by selling stockholders.

      The selling stockholders may, from time to time sell all or a portion of
their registered shares in negotiated transactions or on any exchange in which
we may list or trade our common stock, at prices then prevailing or related to
the then current market price. The shares will not be sold in an underwritten
public offering, but may be sold either directly or through brokers or dealers.
Brokers


                                       29


or dealers may receive commissions or discounts from selling stockholders (or if
any such broker-dealer acts as agent for the purchaser of such shares, from the
purchaser) in amounts to be negotiated which are not expected to exceed those
customary in the types of transactions involved.



- -------------------------------------------------------------------------------------------------------------------
                         Shares Owned                                     Shares Owned             Percentage of
Selling                  Prior to                                         Following                Shares following
Stockholder              Registration             Shares Registered       Registration(1)          Registration
- -------------------------------------------------------------------------------------------------------------------
                                                                                         
- -------------------------------------------------------------------------------------------------------------------
Raja S. Tuli,             1,750,000                  300,000               1,450,000                 24.15%
Chairman of the
Board of Directors
- -------------------------------------------------------------------------------------------------------------------
Norman Docteroff            250,000(2)                83,333                 166,667                  2.77%
- -------------------------------------------------------------------------------------------------------------------
Aarnel Funding               25,000                   25,000                       0
Corp. Pension Plan
- -------------------------------------------------------------------------------------------------------------------
Artas Corporation            40,000                   40,000                       0
- -------------------------------------------------------------------------------------------------------------------
Baker, David                  6,000                    1,000                   5,000
- -------------------------------------------------------------------------------------------------------------------
Barotz, Norman                2,500                    1,500                   1,000
- -------------------------------------------------------------------------------------------------------------------
Berg, Jake                   20,000                   20,000                       0
- -------------------------------------------------------------------------------------------------------------------
Bowen, Ellen, &               1,000                    1,000                       0
Doug
- -------------------------------------------------------------------------------------------------------------------
Brown, Gary                   5,000                    2,000                   3,000
- -------------------------------------------------------------------------------------------------------------------
Bushong, Heather              9,750                    3,000                   6,750
- -------------------------------------------------------------------------------------------------------------------
Calderola, Nancy              3,000                    2,000                   1,000
- -------------------------------------------------------------------------------------------------------------------
Castellano, Anthony          20,000                   12,500                   7,500
- -------------------------------------------------------------------------------------------------------------------
Chianese, Lawrence            1,000                    1,000                       0
- -------------------------------------------------------------------------------------------------------------------
Corsalini, Marie              4,500                    2,000                   2,500
- -------------------------------------------------------------------------------------------------------------------
DiModica, Joseph             10,000                   10,000                       0
- -------------------------------------------------------------------------------------------------------------------
Diversified Investors       701,000                  409,000                 292,000                  4.86%
Capital Services of
North America, Inc.
- -------------------------------------------------------------------------------------------------------------------
Evans, Debra                 42,500                   15,000                  27,500
- -------------------------------------------------------------------------------------------------------------------



                                       30



                                                                                         
- -------------------------------------------------------------------------------------------------------------------
Fam Gindi                     5,000                    5,000                       0
- -------------------------------------------------------------------------------------------------------------------
Finesod, Ben                  5,000                    2,000                   3,000
- -------------------------------------------------------------------------------------------------------------------
Forgione, Diane &             2,500                    2,500                       0
Peter
- -------------------------------------------------------------------------------------------------------------------
Hayhurst, Sandra &
Walter                        2,000                    2,000                       0
- -------------------------------------------------------------------------------------------------------------------
Hazoury, Anandy              25,000                   10,000                  15,000
- -------------------------------------------------------------------------------------------------------------------
Hersch, Andrew               37,500                   12,500                  25,000
- -------------------------------------------------------------------------------------------------------------------
Kaplan, Hilan Trust,            500                      500                       0
Lovey Kaplan
Trustee
- -------------------------------------------------------------------------------------------------------------------
Kessler, Robert              32,500                   10,000                  22,500
- -------------------------------------------------------------------------------------------------------------------
Kramer & Kramer               3,000                    1,000                   2,000
- -------------------------------------------------------------------------------------------------------------------
Leeman, Ira S                20,000                   20,000                       0
- -------------------------------------------------------------------------------------------------------------------
Lerner, Arthur H              5,000                    5,000                       0
- -------------------------------------------------------------------------------------------------------------------
London, Joyce                 2,000                    1,500                     500
- -------------------------------------------------------------------------------------------------------------------
Ludeau, Cedric                5,000                    5,000                       0
- -------------------------------------------------------------------------------------------------------------------
Mancuso, Anthony R.           5,000                    5,000                       0
- -------------------------------------------------------------------------------------------------------------------
Mastey, Henri                 4,000                    2,000                   2,000
- -------------------------------------------------------------------------------------------------------------------
Mastey, Jean Yves             4,000                    2,000                   2,000
- -------------------------------------------------------------------------------------------------------------------
Matrangolo, Stephen           7,500                    7,500                       0
- -------------------------------------------------------------------------------------------------------------------
McKean, Andrew                2,500                    2,500                       0
- -------------------------------------------------------------------------------------------------------------------
Mellis, Lee                   3,000                    1,000                   2,000
- -------------------------------------------------------------------------------------------------------------------
Merchant Ent. Ltd.            2,000                    2,000                   2,000
- -------------------------------------------------------------------------------------------------------------------
Miller, Michael              20,000                   20,000                       0
- -------------------------------------------------------------------------------------------------------------------
Mintz & Fraade,              15,000                   15,000                       0
P.C
- -------------------------------------------------------------------------------------------------------------------
MMH Investments,             37,500                   12,500                  25,000
Inc.
- -------------------------------------------------------------------------------------------------------------------
Pedrignani, Paolo            10,000                    5,000                   5,000
- -------------------------------------------------------------------------------------------------------------------



                                       31



                                                                                         
- -------------------------------------------------------------------------------------------------------------------
Peterson, Brent               1,000                    1,000                       0
- -------------------------------------------------------------------------------------------------------------------
Regency                       5,750                    1,000                   4,750
Resources,Inc
- -------------------------------------------------------------------------------------------------------------------
Rowe, Sandra                  1,000                    1,000                       0
- -------------------------------------------------------------------------------------------------------------------
Schuster,Jerome              50,000                   15,000                  35,000
- -------------------------------------------------------------------------------------------------------------------
Shapiro, Jane                 1,000                    1,000                       0
- -------------------------------------------------------------------------------------------------------------------
Spellane, Tom                 2,000                    2,000                       0
- -------------------------------------------------------------------------------------------------------------------
Steiner, Jeffery              5,000                    2,000                   3,000
- -------------------------------------------------------------------------------------------------------------------
Stepniewski, Jackie           7,000                    2,000                   5,000
- -------------------------------------------------------------------------------------------------------------------
Stone, Gladys                 2,000                    2,000                       0
- -------------------------------------------------------------------------------------------------------------------
Stone, Lawrence              34,500                   34,500                       0
- -------------------------------------------------------------------------------------------------------------------
Telesnick, Alan               9.500                    2,000                   7,500
- -------------------------------------------------------------------------------------------------------------------
Tigrak, Omer                  3,000                    1,000                   2,000
- -------------------------------------------------------------------------------------------------------------------
Tobias, Barbara               4,000                    2,000                   2,000
- -------------------------------------------------------------------------------------------------------------------
Toboroff, Leonard            10,000                    5,000                   5,000
- -------------------------------------------------------------------------------------------------------------------
Toth, Francis                 5,000                    2,000                   3,000
- -------------------------------------------------------------------------------------------------------------------
Tristan, Lucia                2,000                    1,000                   1,000
- -------------------------------------------------------------------------------------------------------------------
Vecchio                      65,000                   65,000                       0
Consultants, Inc.
- -------------------------------------------------------------------------------------------------------------------
Weissman, Jody               8,7500                    2,000                   6,750
- -------------------------------------------------------------------------------------------------------------------
Wells, John                  15,000                    5,000                  10,000
- -------------------------------------------------------------------------------------------------------------------
Wunderlin, Rosalind           1,000                    1,000                       0
- -------------------------------------------------------------------------------------------------------------------
Yablon, Melvin               37,500                   15,000                  22,500
- -------------------------------------------------------------------------------------------------------------------
Zion Morally                  1,000                    1,000                       0
- -------------------------------------------------------------------------------------------------------------------


      (1) Assumes all shares registered pursuant to this prospectus are sold by
the selling shareholders.

      (2) Represents shares available to be purchased pursuant to options issued
to Mr. Docteroff as compensation pursuant to his employment agreement to serve
as our Chief Executive Officer and a director, which provide for the vesting of
options to purchase 6,945 shares of common stock per month.


                                       32


                          DESCRIPTION OF THE SECURITIES

      General

      The following description summarizes our authorized and currently
outstanding securities. We are authorized to issue 12,000,000 shares of common
stock, par value $.001 per share and a maximum of 2,000,000 shares of preferred
stock, $.01 per share. There are 6,002,500 shares of common stock issued and
outstanding as of the date of this prospectus. No shares of preferred stock have
been issued.

      Common Stock

      Each holder of shares of our common stock, issued and outstanding, is
entitled to one vote per share held and has the sole right and power to vote
upon all matters upon which a vote of stockholders is taken. Neither our
certificate of incorporation nor our by laws permit our stockholders to vote
their shares cumulatively. Upon liquidation, dissolution, or winding up of our
business, the owners of common stock are entitled to receive our net assets in
proportion to the respective number of shares held by them, following payment to
our preferred stockholders. The holders of Common Stock do not have any
preemptive right to subscribe for or purchase any Shares of any class of stock.
All of our outstanding shares of common stock are fully paid and non-assessable
and not subject to further call or redemption.

      To date, we have never paid dividends on any of our common stock and we
intend to reinvest earnings, if any, for the development and expansion of our
business. We do not guarantee that we will have enough earnings to pay any
dividends on our common stock. Even if we have sufficient earnings, we are not
required to declare dividends on our common stock. Whether we should declare
cash or stock dividends will be in the sole and absolute discretion of our board
and will depend on our earnings, capital requirements, financial position,
general economic conditions and other relevant factors. It is also possible that
the terms of any future debt financing may restrict declaration of dividends.

Preferred Stock

      We are authorized by our certificate of incorporation to issue preferred
stock, in one or more series which may contain rights, privileges and
limitations, including:

            o   conversion privileges              o   dividends
            o   redemption rights                  o   liquidation privileges.

      Except as specifically provided by the Delaware General Corporation Law
relating to the voting by all classes of stock, holders of preferred stock will
have no voting rights unless specifically granted by our board. We have not
issued any of our preferred stock, as of the date of this prospectus and
currently have no plans to do so.

      If any shares of preferred stock are issued, a certificate of designation,
setting forth the series of such preferred stock and the rights, privileges and
limitations of the holders of the preferred stock will be filed with the
Secretary of State of the State of Delaware. This may have the effect the of


                                       33


delaying, deferring or preventing a change in control of our management without
further action by other stockholders and may adversely affect the rights of the
holders of our common stock.

Warrants

      In July 1996 we conducted a private offering pursuant to Rule 504 of the
Securities Act of 1933, as amended. The offering raised $575,000 which we used
as working capital and to assist research and development of our products. Each
investor in the 1996 private offering purchased a unit (or a fractional unit)
valued at $50,000. Each unit consisted of the following: (a) a $50,000
promissory note bearing 10% interest per year and maturing upon the earlier of
two years from issuance or the effective date of an initial public offering; (b)
10,000 shares of common stock, which were exchanged for 15,000 shares of our
common stock upon the exchange of common stock (the "Exchange") in our Canadian
subsidiary for our common stock; and (c) 10,000 common stock purchase warrants,
which were exchanged for 15,000 common stock purchase warrants upon the exchange
of common stock in our Canadian subsidiary for our common stock.

      In February, 1999 we offered an extension agreement to the investors of
the 1996 offering which extended the due date of the Promissory Notes which were
part of the 1996 private offering. Sixteen of the 18 investors agreed to the
extension. As compensation to the investors who agreed to the extension, we: (A)
issued additional warrants equal to the number of the warrants held (as adjusted
upon the Exchange) with an exercise price of $0.10 per share and (B) the
exercise price for the warrants originally issued in connection with the 1996
private offering was reduced from $1.67 (as adjusted) to $0.10. The extension
agreement extended the due date for the Promissory Notes until the earlier to
occur of either (a) August 1, 2000; or (b) the raising an aggregate of
$5,000,000 in financing.

      Warrant holders may exercise their rights by surrendering the warrant
certificate to us, with the fully completed and executed subscription form,
together with payment of the exercise price. Commencing upon the date of the
purchase, the warrants may be exercised at any time in whole or part at the
applicable exercise price until the warrants expire. We will not issue
fractional shares when the warrants are exercised.

      The exercise price and the number of shares of common stock purchased upon
the exercise of the warrants are subject to adjustment if certain events were
occur such as stock dividends, stock splits, combinations or reclassifications
of the common stock. Additionally, an adjustment would be made in the case of a
reclassification or exchange of common stock, or if we were to consolidation or
merge, in order to enable warrant holders to acquire the kind and number of
shares of stock or other securities or property receivable in such event by a
holder of the number of shares of common stock that might have been purchased
upon the exercise of the warrant.

Previous Private Offerings

      In July, 1996, we conducted a private offering, pursuant to Rule 504 of
Regulation D of the Securities Act of 1933, as amended, in which it raised
$575,000. Each investor in the 1996 offering purchased units consisting of the
following securities: (i) a $50,000 non-negotiable promissory note at 10%
interest, due at the earlier of either two years after the closing of the
private placement or an initial public offering, (ii) 10,000 shares of our
common stock, and (iii) a warrant to purchase 10,000


                                       34


shares of our common stock at a purchase price of $2.50 per share one year
following an initial public offering and expiring five years following the
initial public offering, however, no provisions have been made if we do not
conduct an initial public offering. In February 1999, investors in the 1996
private placement were offered an extension agreement which extended the due
date of the promissory note in exchange for additional warrants equal to 1.5
times the number of original warrants to adjust for the exchange of shares of
common stock in our Canadian subsidiary for shares of our common stock on a
three for two basis, at a purchase price of $.10 per share. In addition, the
original purchase price of the warrants was reduced from $1.67 (as adjusted) to
$0.10. Sixteen of the eighteen investors in the 1996 private placement agreed to
this extension, executing extension agreements.

      In March, 1999 Docuport Delaware commenced a private offering of shares,
pursuant to Rule 504 of Regulation D of the Securities Act of 1933, as amended,
of its common stock, which closed in April selling 700,000 shares at a purchase
price of $.10 per share. The shares purchased in the March, 1999 offering are
restricted and are not freely transferrable until the earlier of either one year
following purchase of the shares or registration of the shares with the SEC.

      On March 24, 1999, our board and the board of our Canadian subsidiary,
authorized the exchange of all of the issued and outstanding shares and warrants
of the Canadian corporation into our shares or warrants to purchase our shares
on a 3 for 2 basis. Thus, for every 100 shares of the Canadian corporation's
common stock, a stockholder received 150 shares of our common stock. The
Canadian subsidiary continues in existence as our subsidiary.

      In April, 1999 Docuport Delaware concluded a private offering, pursuant to
Rule 504 of Regulation D of the Securities Act of 1933, as amended, of shares of
our common stock, selling 435,000 shares at a purchase price of $2.00 per share.

Shares Eligible for Future Sale

      We currently have outstanding 6,002,500 shares of common stock. Of these
shares 1,150,000 (excluding shares underlying options granted to Norman
Docteroff as compensation in connection with his employment agreement to serve
as our Chief Executive Officer and a director) will be registered pursuant to
this registration statement and will be freely transferable without restriction
or further registration under the Securities Act. In addition, we have issued an
aggregate of 607,500 shares in private offerings pursuant to Rule 504 of the
Securities Act of 1933, as amended. These shares, while not registered with the
SEC are freely transferable by their respective owners.

      All of the remaining 4,245,000 shares of our outstanding common stock
outstanding are "restricted securities," as that term is defined in Rule 144
promulgated under the Securities Act, and may only be sold pursuant to an
effective registration statement under the Securities Act, or in compliance with
the exemption provisions of Rule 144 or pursuant to another exemption under the
Securities Act.

      In general, under Rule 144 as currently in effect, any person (or persons
whose shares are aggregated) who has beneficially owned restricted securities
for at least one year is entitled to sell,


                                       35


within any three-month period, a number of shares that does not exceed the
greater of 1% of the then outstanding shares of the issuer's common stock or the
average weekly trading volume during the four calendar weeks preceding such
sale, provided that certain public information about the issuer as required by
Rule 144 is then available and the seller complies with certain other
requirements. Affiliates may sell unrestricted securities in compliance with
Rule 144, other than the holding period requirement. A person who is not an
affiliate, has not been affiliate within two months prior to sale, and has
beneficially owned the restricted securities for at least two years, is entitled
to sell such shares under Rule 144 without regard to any of the limitations
described above.

      Prior to this registration, there has been no public trading market for
the common stock and we cannot predict the effect, if any, that public sales of
shares of common stock or the availability of shares for sale will have on the
market prices of the common stock and warrants. Nevertheless, the possibility
that a substantial amount of common stock or warrants may be sold in the public
market may adversely effect prevailing market prices and could impair our
ability to raise capital through the sale of its equity securities.

Determination of Offering Price

      Prior to this registration of our common stock, there has been no public
market for any of our securities and there can be no assurance that a market
will develop. In recent private offerings of our securities, we have sold our
common stock at prices of $.10 and $2.00. The price of our common stock, when
sold by our stockholders will be determined by broker-dealers and market makers
in negotiated transactions, or trades over the open market where we intend to
list our common stock. Among factors which may be considered by broker-dealers,
market makers and investors to determine the price for our securities in the
public market are:

      o estimates of our business potential;

      o prevailing market conditions in the U.S. economy and the market in which
we intend to compete;

      o an evaluation of other companies comparable to us and their ability to
effectively compete with our product.

Transfer Agent

      The transfer agent for our common stock is Liberty Transfer Company, 191
New York Avenue, Huntington, New York 11243.

                      INTEREST OF NAMED EXPERTS AND COUNSEL

Legal Matters

      The legality of our common stock has been passed upon on our behalf by
Mintz & Fraade, P.C., New York, New York. Mintz & Fraade, P.C. beneficially owns
15,000 shares of our common stock.

Experts


                                       36


      The financial statements included in this prospectus and in the
Registration Statement have been audited by BDO Dunwoody, independent chartered
accountants, to the extent and for the periods set forth in their report
appearing elsewhere herein and in the Registration Statement, and are included
in reliance upon such reports given upon the authority of said firm as experts
in accounting and auditing.

                                LEGAL PROCEEDINGS

      We do not know of any litigation pending, threatened or contemplated, or
unsatisfied judgments, against us, or of any proceeding to which we are a party.

                              AVAILABLE INFORMATION

      We have filed with the Securities and Exchange Commission a registration
statement on Form SB-2 under the Securities Act (together with all amendments
and exhibits) for the securities registered by this registration statement. This
Prospectus, filed as a part of the registration statement, does not contain all
of the information set forth in, or annexed as exhibits to, the registration
statement, certain parts of which are omitted in accordance with the rules and
regulations of the commission. For further information about us, please refer to
the registration statement, including its exhibits and schedules, which may be
inspected without charge at the principal office of the commission, 450 Fifth
Street, NW, Washington, D.C. 20549, or at other regional offices of the
commission. Copies of such material may be obtained by mail from the Public
Reference Section of the Commission at 450 Fifth Street, NW, Washington, D.C.
20549, at prescribed rates. Such material may also be accessed electronically at
the SEC's home page on the Internet at http://www.sec.gov.


                                       37


- --------------------------------------------------------------------------------

                                 Docuport, Inc.

                                1,233,333 Shares

                                 --------------
                                   PROSPECTUS
                                 --------------

      We have not authorized anyone to give any information or to make any
representations other than those contained in this Prospectus. No other
information should be relied upon. The information contained in this prospectus
is current only to the date of this prospectus. This Prospectus does not offer
to sell any securities in any jurisdiction where to do so would be unlawful.

                                   ----------

Until        , 1999 (25 days after the date of this prospectus), all dealers
effecting transactions in the registered securities, whether or not
participating in this distribution, may be required to deliver a prospectus.
This is in addition to the obligations of dealers to deliver a prospectus when
acting as underwriters and with respect to their unsold allotments or
subscriptions.

                                  ______ , 1999


================================================================================


                                       38


                          INDEX TO FINANCIAL STATEMENTS

Independent Auditors' Report .............................................. F-2

Audited Balance Sheets as of December 31, 1998 ............................ F-3

Statements of Operations, for the Period of Inception
Through the Fiscal Year Ended December 31, 1998 ........................... F-4

Statements of Stockholders' Deficiency, for the Period of
Inception Through Fiscal Years Ended December 31, 1997 and
December 31, 1998 ......................................................... F-5

Statements of Cash Flows, for the Period of Inception
Through Fiscal Years Ended December 31, 1997 and
December 31, 1998.......................................................... F-6

Notes to Financial Statements ............................................. F-7

Balance Sheets as of March 31, 1999 (unaudited) ........................... F-12

Statements of Operation, for the Period of Inception Through
Three months ended March 31, 1999 and March 31, 1998 (unaudited)........... F-13

Statements of Shareholders' Deficiency for the Period of
Inception Through Three months ended March 31, 1999 and
March 31, 1998 (unaudited) ................................................ F-14

Statements of Cash Flows, for the Period of Inception
Through Three Months ended March 31, 1999 and
March 31, 1998 (Unaudited) ................................................ F-15

Notes to Unaudited Financial Statements.................................... F-16


                                      F-1


================================================================================

                                                                Auditors' Report

- --------------------------------------------------------------------------------

To the Directors of
DOCUPORT INC.

We have audited the balance sheets of Docuport Inc. (a development stage
company) as at December 31, 1998 and December 31, 1997 and the statements of
operations, shareholders' deficiency and cash flows for the period from February
1st, 1992, date of inception, through December 31, 1998 and for the years ended
December 31, 1998 and December 31, 1997. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing standards
in Canada. Those standards require that we plan and perform an audit to obtain
reasonable assurance whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.

In our opinion, these financial statements present fairly, in all material
respects, the financial position of the Company as at December 31, 1998 and 1997
and the results of its operations and the changes in its cash flow for the
period from February 1st, 1992, date of inception, through December 31, 1998 and
for the years ended December 31, 1998 and December 31, 1997 in accordance with
generally accepted accounting principles in the United States.


/s/ BDO Dunwoody LLP

Chartered Accountants

Montreal, Quebec
February 12, 1999


                                      F-2


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                                                  Balance Sheets
                                            (Expressed in United States dollars)

December 31                                              1998            1997
- --------------------------------------------------------------------------------

Assets

Current
  Cash and cash equivalents                           $ 117,899       $  10,822
  Miscellaneous receivable                                3,142           2,954
  Income tax credits receivable                          25,415         145,748
  Advance to employee (Note 1)                               --           3,454
                                                      -------------------------
                                                        146,456         162,978
Capital assets (Note 2)                                   7,067          10,265
                                                      -------------------------
                                                      $ 153,523       $ 173,243
================================================================================

Liabilities and Shareholders' Deficiency

Current
  Accounts payable and accrued liabilities            $ 167,605       $  85,134
  Due to related parties (Note 3)                        25,289           3,454
  Current portion of long term debt (Note 4)            575,000         575,000
                                                      -------------------------
                                                        767,894         663,588
                                                      -------------------------

Shareholders' deficiency
  Share capital (Note 5)                                     73              73
  Deficit accumulated during the development stage     (672,182)       (515,703)
  Cumulative translation adjustment                      57,738          25,285
                                                      -------------------------
                                                       (614,371)       (490,345)
                                                      -------------------------
                                                      $ 153,523       $ 173,243
================================================================================

           See accompanying summary of significant accounting policies
                    and notes to these financial statements.


                                      F-3


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                                        Statements of Operations
                                            (Expressed in United States dollars)



                                       February 1, 1992 to        Year ended        Year ended
                                              December 31,      December 31,      December 31,
                                                      1998              1998              1997
- ----------------------------------------------------------------------------------------------
                                                                          
Expenses
  Amortization                                 $     6,907       $     2,948       $     2,767
  Foreign exchange loss                             64,163            32,142            32,021
  Materials                                        107,896            17,482            68,423
  Office                                            36,044             8,284            19,742
  Professional fees                                 19,290            10,146             5,555
  Rent                                               8,802             2,451             2,626
  Research and development tax credits            (166,509)          (13,482)          (93,897)
  Salaries and employees benefits                  155,262            29,552            90,721
  Subcontractors                                   126,221                --            64,837
  Taxes and licences                                 1,406               535               871
  Travel                                            27,835             4,415            19,922
                                               -----------------------------------------------
Operating loss before undernoted                  (387,317)          (94,473)         (213,588)
                                               -----------------------------------------------

Other income and expenses
  Interest income                                   11,152               113             6,124
  Financing fees                                  (155,336)           (3,640)          (53,155)
  Interest and bank charges                         (2,613)             (909)           (1,330)
  Interest on long term debt                      (138,068)          (57,570)          (61,373)
                                               -----------------------------------------------
                                                  (284,865)          (62,006)         (109,734)
                                               -----------------------------------------------
Net loss                                       $  (672,182)      $  (156,479)      $  (323,322)
==============================================================================================

Loss per common share, basic and diluted       $     (0.22)      $     (0.05)      $     (0.11)
==============================================================================================

Weighted average number of shares
  outstanding                                    3,015,000         3,015,000         3,015,000
==============================================================================================


           See accompanying summary of significant accounting policies
                    and notes to these financial statements.


                                      F-4


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                          Statements of Shareholders' Deficiency
                                            (Expressed in United States dollars)

For the period from February 1, 1992, date of inception, through December 31,
1998
- --------------------------------------------------------------------------------



                                               Accumulated
                                                     Other
                                                Comprehen-                    Comprehen-
                                       Common         sive                          sive
                                       Shares         Loss        Deficit           Loss          Total
                                       ----------------------------------------------------------------
                                                                               
Balance, February 1, 1992              $  --      $     --      $      --                     $      --

  2,900,000 Common shares
    issued in 1992 for
    $ 0.0000251 per share                 73            --             --                            73

  115,000 common shares
    issued in 1996 for nil
    consideration                         --            --             --                            --

  Comprehensive loss
    Net loss for the period               --            --       (192,381)     $(192,381)      (192,381)

  Other comprehensive income
    Foreign currency
      translation adjustments             --           909             --            909            909
                                                                               ---------

  Comprehensive loss                      --            --             --      $(191,472)
                                       ----------------------------------      =========      ---------

Balance, December 31, 1997                73           909       (192,381)                     (191,399)

  Comprehensive loss
    Net loss for the year                 --            --       (323,322)     $(323,322)      (323,322)

  Other comprehensive income
    Foreign currency
      translation adjustments             --        24,376             --         24,376         24,376
                                                                               ---------

  Comprehensive loss                      --            --             --      $(298,946)
                                       ----------------------------------      =========      ---------

Balance, December 31, 1997                73        25,285       (515,703)                     (490,345)

  Comprehensive loss
    Net loss for the year                 --            --       (156,479)     $(156,479)      (156,479)

  Other comprehensive income
    Foreign currency
      translation adjustments             --        32,453             --         32,453         32,453
                                                                               ---------      ---------

  Comprehensive loss                      --            --             --      $(124,026)
                                       ----------------------------------      =========

Balance, December 31, 1998             $  73      $ 57,738      $(672,182)                    $(614,371)
=========================================================================                     =========


           See accompanying summary of significant accounting policies
                    and notes to these financial statements.


                                      F-5


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                                        Statements of Cash Flows
                                            (Expressed in United States dollars)



                                             February 1, 1992 to      Year ended      Year ended
                                                    December 31,    December 31,    December 31,
                                                            1998            1998            1997
- ------------------------------------------------------------------------------------------------
                                                                              
Cash provided by (used in)

Operating activities
  Net loss                                             $(672,182)      $(156,479)      $(323,322)
  Add (deduct) items not requiring a cash outlay
    Amortization                                           6,907           2,948           2,767
    Foreign exchange loss                                 64,163          32,142          32,021
  Net changes in assets
      and liabilities related to operations
    Accounts receivable                                   (3,142)           (188)           (913)
    Income tax credits receivable                        (25,415)        120,333         (86,650)
    Accounts payable and accrued liabilities             167,605          82,471          60,368
    Other assets                                             250             250              --
                                                       -----------------------------------------
                                                        (461,814)         81,477        (315,729)
                                                       -----------------------------------------

Investing activities
  Purchase of capital assets                             (14,224)             --          (7,554)
  Advances to employee                                        --           3,454          (3,454)
                                                       -----------------------------------------
                                                         (14,224)          3,454         (11,008)
                                                       -----------------------------------------

Financing activities
  Due to related parties                                  25,289          21,835            (194)
  Long term debt issued                                  575,000              --              --
  Shares issued                                               73              --              --
                                                       -----------------------------------------
                                                         600,362          21,835            (194)
                                                       -----------------------------------------

Effect of exchange rate changes on cash                   (6,425)            311          (4,892)
                                                       -----------------------------------------
Net increase (decrease) in cash during the period        117,899         107,077        (331,823)

Cash and equivalents, beginning of period                     --          10,822         342,645
                                                       -----------------------------------------
Cash and equivalents, end of period                    $ 117,899       $ 117,899       $  10,822
================================================================================================


Note: See Note 8 for supplementary information

           See accompanying summary of significant accounting policies
                    and notes to these financial statements.


                                      F-6


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                      Summary of Significant Accounting Policies
                                            (Expressed in United States dollars)

December 31, 1998 and 1997
- --------------------------------------------------------------------------------

Nature of Business                 Docuport Inc. (the "Company") was
                                   incorporated under the laws of Ontario in
                                   February 1992 and was inactive until January
                                   1, 1996, the inception date. The Company is
                                   developing and intends to market a patented
                                   portable multifunctional office machine
                                   called the Slimfax. The Company's future
                                   operations is dependent upon successful
                                   marketing and sales of its product and
                                   obtaining the necessary financing to complete
                                   the development.

Basis of Financial Statements      The accompanying consolidated financial
                                   statements are stated in United States
                                   dollars, "the reporting currency". The
                                   transactions of the Company have been
                                   recorded during the year in Canadian dollars,
                                   "the functional currency". The translation of
                                   Canadian dollars into United States dollars
                                   amounts have been made at the year end
                                   exchange rates for balance sheet items and
                                   the average exchange rate for the year for
                                   revenues, expenses, gains and losses.
                                   Translation adjustments to reporting currency
                                   are included in equity.

                                   These financial statements have been prepared
                                   by management in accordance with generally
                                   accepted accounting principles in the United
                                   States.

Accounting Estimates               The preparation of financial statements in
                                   conformity with generally accepted accounting
                                   principles requires management to make
                                   estimates and assumptions that affect the
                                   reported amounts of assets and liabilities
                                   and disclosure of contingent assets and
                                   liabilities at the date of the financial
                                   statements and the reported amounts of
                                   revenues and expenses during the reporting
                                   period. Actual results could differ from
                                   those estimated.

Capital Assets                     Management reviews long-lived assets for
                                   impairment whenever events or changes in
                                   circumstances indicate that the carrying
                                   amount of an asset may not be recoverable,
                                   and, if deemed impaired, measurement and
                                   recording of an impairment loss is based on
                                   the fair value of the asset.

                                   Capital assets are recorded at cost less
                                   accumulated amortization. Amortization is
                                   provided annually at rates calculated to
                                   amortize the assets over their estimated
                                   useful lives as follows:

                                   Furniture and fixtures - 20% declining
                                                            balance

                                   Computer equipment     - 30% declining
                                                            balance

Cash and Equivalents               Cash and cash equivalents include all highly
                                   liquid investments purchased with original
                                   maturities of three months or less.


                                      F-7


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                          Summary of Significant Accounting Policies (continued)
                                            (Expressed in United States dollars)

December 31, 1998 and 1997
- --------------------------------------------------------------------------------

Recently Issued Accounting         SFAS No 133, "Accounting for Derivatives
Standards                          Instruments and Hedging Activities" requires
                                   companies to record derivatives on the
                                   balance sheet as assets or liabilities,
                                   measured at fair market value. Gains or
                                   losses resulting from changes in the values
                                   of those derivatives are accounted for
                                   depending on the use of the derivative and
                                   whether it qualifies for hedge accounting.
                                   The key criterion for hedge accounting is
                                   that the hedging relationship must be highly
                                   effective in achieving offsetting changes in
                                   fair value or cash flows. SFAS No. 133 is
                                   effective for fiscal years beginning after
                                   June 15, 1999. Management believes that the
                                   adoption of SFAS No. 133 will have no
                                   material effect on its financial statements.

                                   SOP 98-5, "Reporting on the Costs of Start-Up
                                   Activities," requires that the costs of
                                   start-up activities, including organization
                                   costs, be expensed as incurred. This
                                   Statement is effective for financial
                                   statements issued for fiscal years beginning
                                   after December 15, 1998. Management believes
                                   that the adoption of SOP 98-5 will have no
                                   material effect on its financial statements.

Research and                       Research and development costs are charged
Development Costs                  against income in the year of expenditure.

Income Taxes                       The Company accounts for income taxes under
                                   the asset and liability method as required by
                                   SFAS No. 109, Accounting for Income Taxes.
                                   Under the asset and liability method,
                                   deferred income taxes are recognized for the
                                   tax consequences of temporary differences by
                                   applying enacted tax rates applicable to
                                   future years to differences between the
                                   financial statements carrying amounts and the
                                   tax bases of existing assets and liabilities.
                                   When tax credits are available, they are
                                   recognized as reductions of current year's
                                   tax expense.

Fair Value of                      The carrying amounts of financial instruments
Financial                          of the Company, Instruments including cash
                                   and cash equivalents, accounts receivable,
                                   and accounts payable approximate fair value
                                   because of their short maturity. The fair
                                   value of advances to and from related parties
                                   and long term debt cannot be readily
                                   determined.

Earnings (loss) per share          Earnings (loss) per common share is based on
                                   the weighted average number of common shares
                                   outstanding during the period. The effect of
                                   common shares contingently issuable pursuant
                                   to outstanding warrants has not been
                                   considered since they are anti-dilutive.


                                      F-8


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                                   Notes to Financial Statements
                                            (Expressed in United States dollars)

December 31, 1998 and 1997
- --------------------------------------------------------------------------------

1.    Advance to Employee

      The advance is non-interest bearing and without specific terms of
      repayment.

- --------------------------------------------------------------------------------

2.    Capital Assets

                                                              1998         1997
                                  ---------------------------------------------

                                           Accumulated    Net Book     Net Book
                                     Cost Amortization       Value        Value

      Furniture and fixtures      $ 1,176      $   351     $   825      $   820
      Computer equipment           12,081        5,839       6,242        9,445
                                  ---------------------------------------------

                                  $13,257      $ 6,190     $ 7,067      $10,265
                                  =============================================

- --------------------------------------------------------------------------------

3.    Due to Related Parties and Related Party Transactions

      The amounts due to related parties are non-interest bearing with no
      specific terms of repayment.

      From February 1, 1992 to December 31, 1998 the Company subcontracted
      software and other consulting projects totalling $111,557 with various
      companies controlled by shareholders.

      During 1997 the Company subcontracted software consulting projects
      totalling $64,837 with various companies controlled by shareholders.

      During 1998 the Company incurred rent charges from a related company
      totalling $2,451 (1997 - $2,626).

      These transactions were in the normal course of business and were measured
      at the exchange amount, which is the amount of consideration established
      and agreed to by the related companies.

- --------------------------------------------------------------------------------

4.    Long Term Debt

                                                                  1998      1997
                                                              ------------------

      10% subordinated promissory notes, due August 28, 1998  $575,000  $575,000
                                                              ==================

      The Company is currently in default as the notes were due August 28, 1998.
      The Company is presently negotiating an extention with the noteholders and
      the debt has been reflected as current.

- --------------------------------------------------------------------------------


                                      F-9


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                                   Notes to Financial Statements
                                            (Expressed in United States dollars)

December 31, 1998 and 1997
- --------------------------------------------------------------------------------

5.    Share Capital

      (a)   Authorized

            Unlimited amount of common shares of no par value

      (b)   Issued and outstanding

                                                                 1998       1997
                                                                ----------------

            3,015,000 Common shares                             $  73      $  73
                                                                ================

      (c)   Warrants

            In connection with the subordinated promissory notes (see Note 4),
            the Company has issued to the noteholders 115,000 warrants to
            purchase common shares at an exercise price of $2.50. The warrants
            expire August 28, 2002.

- --------------------------------------------------------------------------------

6.    Income Taxes

      (a)   The reconciliation of income taxes calculated at the effective tax
            rate of 18.87% to the total tax provision is as follows:

                                                            1998           1997
                                                        -----------------------

            Income taxes (recovery) at statutory
              rates                                     $(29,528)      $(61,011)
            Adjustment to valuation adjustment            29,528         61,011
                                                        -----------------------
                                                        $     --             --
                                                        =======================

      (b)   Deferred Tax Assets

            Deferred tax assets have been recorded at current rates as follows:

            Balance of pool of Scientific Research &
              Development available to reduce taxable
              income for future years                   $     --       $ 41,000

            Tax losses available to reduce taxable
              income of future years                     116,000         59,000
                                                        -----------------------
                                                         116,000        100,000
            Less: Deferred tax asset valuation
              allowance                                  116,000        100,000
                                                        -----------------------
            Net tax asset                               $     --       $     --
                                                        =======================

            The Company has net operation loss carryforwards to reduce taxable
            income of approximately $614,000 which expire during the years 2003
            through 2005.


                                      F-10


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                                   Notes to Financial Statements
                                            (Expressed in United States dollars)

December 31, 1998 and 1997
- --------------------------------------------------------------------------------

7.    Commitment

      The Company is committed under a management and consulting agreement for a
      three year period ending December 2001 for compensation consisting of
      700,000 shares which will be transferred from the present shareholders. In
      addition, the Company is committed to the consultant for a fee of $5,000
      per month for a two year period after such time the Company becomes
      publicly traded.

- --------------------------------------------------------------------------------

8.    Supplemental Disclosure of Cash Flow Information

            Cash paid during the year:

                                                            1998           1997
                                                        -----------------------

            Interest                                    $ 58,479       $ 62,703
                                                        =======================

            There are no non-monetary transactions during the years.

- --------------------------------------------------------------------------------


                                      F-11


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                                                  Balance Sheets
                                            (Expressed in United States dollars)

As at March 31                                             1999            1998
- --------------------------------------------------------------------------------
                                                     (Unaudited)     (Unaudited)
Assets

Current
  Cash and cash equivalents                           $  28,267       $   2,163
  Miscellaneous receivable                                3,146           2,981
  Income tax credits receivable                          21,941         148,612
  Advance to employee                                        --           3,522
                                                      -------------------------

                                                         53,354         157,278
Capital assets                                            6,790           9,703
                                                      -------------------------
                                                      $  60,144       $ 166,981
================================================================================

Liabilities and Shareholders' Deficiency

Current
  Accounts payable and accrued liabilities            $ 158,890       $ 104,148
  Due to related parties                                 25,113          11,205
  Current portion of long term debt                     575,000         575,000
                                                      -------------------------
                                                        759,003         690,353
                                                      -------------------------

Shareholders' deficiency
  Share capital                                              73              73
  Deficit accumulated during the development stage     (746,079)       (538,924)
  Cumulative translation adjustment                      47,147          15,479
                                                      -------------------------
                                                       (698,859)       (523,372)
                                                      -------------------------
                                                      $  60,144       $ 166,981
================================================================================


                                      F-12


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                                        Statements of Operations
                                            (Expressed in United States dollars)



                                      February 1, 1992 to    3 months ended    3 months  ended
                                                March 31,         March 31,          March 31,
                                                     1999              1999              1998
- ---------------------------------------------------------------------------------------------
                                               (Unaudited)       (Unaudited)       (Unaudited)
                                                                         
Expenses
  Amortization                                $     7,274       $       367       $       580
  Foreign exchange loss (gain)                     54,461            (9,702)          (10,248)
  Materials                                       127,445            19,549                --
  Office                                           44,765             8,721             3,708
  Professional fees                                21,606             2,316             2,797
  Rent                                              8,802                --               636
  Research and development tax credits           (166,509)               --                --
  Salaries and employees benefits                 190,516            35,254            11,282
  Subcontractors                                  126,221                --                --
  Taxes and licences                                1,423                17                --
  Travel                                           30,554             2,719                --
                                              -----------------------------------------------
Operating loss before undernoted                 (446,558)          (59,241)           (8,755)
                                              -----------------------------------------------

Other income and expenses
  Interest income                                  11,152                --                --
  Financing fees                                 (155,336)               --                --
  Interest and bank charges                        (2,613)               --               (90)
  Interest on long term debt                     (152,724)          (14,656)          (14,376)
                                              -----------------------------------------------
                                                 (299,521)          (14,656)          (14,466)
                                              -----------------------------------------------
Net loss                                      $  (746,079)      $   (73,897)      $   (23,221)
=============================================================================================

Less per common share, basic and diluted      $     (0.25)      $     (0.02)      $     (0.01)
=============================================================================================

Weighted average number of shares
  outstanding                                   3,015,000         3,015,000         3,015,000
=============================================================================================



                                      F-13


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                          Statements of Shareholders' Deficiency
                                            (Expressed in United States dollars)

For the periods from February 1, 1992, date of inception, to March 31, 1999 and
for the three months ended March 31, 1999 and 1998
- --------------------------------------------------------------------------------



                                            Accumulated
                                                  Other
                                             Comprehen-                       Comprehen-
                                   Common          sive                             sive
                                   Shares          loss         Deficit             loss            Total
                               --------------------------------------------------------------------------
                               (Unaudited)   (Unaudited)     (Unaudited)      (Unaudited)      (Unaudited)
                                                                                
Balance, February 1, 1992           $  --      $     --      $       --                        $       --

  2,900,000 Common shares
    issued in 1992 for
    $ 0.0000251 per share              73            --              --                                73

  115,000 common shares
    issued in 1996 for nil
    consideration                      --            --              --                                --

  Comprehensive loss
    Net loss from inception to
    March 31, 1999                     --            --        (746,079)      $ (746,079)        (746,079)

  Other comprehensive income
    Foreign currency
      translation adjustments          --        47,147              --           47,147          47,147
                                                                              ----------
  Comprehensive loss                   --            --              --        $(698,932)
                                    -----------------------------------       ==========       ----------

Balance, March 31, 1999             $  73      $ 47,147      $ (746,079)                       $ (698,859)
=======================================================================                        ==========

Balance, January 1, 1999            $  73      $ 57,738      $ (672,182)      $       --       $ (614,371)

  Comprehensive loss
    Net loss for the period            --            --         (73,897)      $  (73,897)         (73,897)

  Other comprehensive income
    Foreign currency
      translation adjustments          --       (10,591)             --          (10,591)         (10,591)
                                                                              ----------
  Comprehensive loss                   --            --              --       $  (84,488)              --
                                    -----------------------------------       ==========

Balance, March 31, 1999             $  73      $ 47,147      $ (746,079)                       $ (698,859)
=======================================================================                        ==========

Balance, January 1, 1998            $  73      $ 25,285      $ (515,703)                       $ (490,345)

  Comprehensive loss
    Net loss for the period            --            --         (23,221)      $  (23,221)         (23,221)

  Other comprehensive income
    Foreign currency
      translation adjustments          --        (9,806)             --           (9,806)          (9,806)
                                                                              ----------       ----------
  Comprehensive loss                   --            --              --       $  (33,027)
                                    -----------------------------------       ==========

Balance, March 31, 1998             $  73      $ 15,479      $ (538,924)                       $ (523,372)
=======================================================================                        ==========



                                      F-14


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                                        Statements of Cash Flows
                                            (Expressed in United States dollars)



                                           February 1, 1992  to  3 months ended  3 months ended
                                                      March 31,       March 31,       March 31,
                                                           1999            1999            1998
- -----------------------------------------------------------------------------------------------
                                                                             
                                                     (Unaudited)     (Unaudited)     (Unaudited)
Cash provided by (used in)

Operating activities
  Net loss                                            $(746,079)      $ (73,897)      $ (23,221)
  Add (deduct) items not requiring a cash outlay
    Amortization                                          7,274             367             580
    Foreign exchange loss (gain)                         54,461          (9,702)        (10,248)
  Net changes in assets
      and liabilities related to operations
    Accounts receivable                                  (3,146)             (4)            (27)
    Income tax credits receivable                       (21,941)          3,474          (2,864)
    Accounts payable and accrued liabilities            158,890          (8,715)         19,014
    Decrease in other assets                                250             250              --
                                                      -----------------------------------------
                                                       (550,291)        (88,227)        (16,766)
                                                      -----------------------------------------

Investing activities
  Purchase of capital assets                            (14,314)            (90)            (18)
  Advances to employee                                       --              --             (68)
                                                      -----------------------------------------
                                                        (14,314)            (90)            (86)
                                                      -----------------------------------------

Financing activities
  Due to related parties                                 25,113            (176)          7,751
  Long term debt issued                                 575,000              --              --
  Shares issued                                              73              --              --
                                                      -----------------------------------------
                                                        600,186            (176)          7,751
                                                      -----------------------------------------

Effect of exchange rate changes on cash                  (7,314)         (1,139)            442
                                                      -----------------------------------------

Net increase (decrease) in cash
  and equivalents during the period                      28,267         (89,632)         (8,659)

Cash and equivalents, beginning of period                    --         117,899          10,822
                                                      -----------------------------------------
Cash and equivalents, end of period                   $  28,267       $  28,267       $   2,163
===============================================================================================



                                      F-15


================================================================================
                                                                   DOCUPORT INC.
                                                   (a development stage company)
                                         Notes to Unaudited Financial Statements

March 31, 1999 and 1998
- --------------------------------------------------------------------------------

1.    Basis of presentation

      The financial statements as of March 31, 1999 and 1998 and for the periods
      from February 1st, 1992, date of inception, to March 31, 1999 and for the
      three-month periods ended March 31, 1999 and March 31, 1998, include, in
      the opinion of management, all normal recurring adjustments necessary to
      present fairly the financial position, results of operations and cash
      flows at March 31, 1999 and for all periods presented.

      Certain information and footnote disclosures normally included in the
      financial statements prepared in accordance with generally accepted
      accounting principles have been omitted. It is suggested that these
      financial statements be read in conjunction with the financial statements
      and notes thereto incorporated by reference in the company's financial
      statements for the year ending December 31, 1998. The results of
      operations for the three-month periods ended March 31, 1999 and 1998 are
      not necessarily indicative of the operating results to be expected for the
      full year.

- --------------------------------------------------------------------------------

2.    Subsequent Events

      In February, 1999 the Company offered an extension agreement to the
      investors of the 1996 private offering which extended the due date of the
      promissory notes. The agreement extended the due date of the promissory
      notes to the earlier to occur of either (a) August 1, 2000; or (b) the
      raising of an aggregate of $5,000,000 in financing. Sixteen of the
      eighteen investors agreed to the extension and those who agreed were
      granted additional warrants equal to the number of warrants held with an
      exercise price of $0.10 per share and the exercise price of their original
      warrants was reduced to $0.10 per share from $2.50.

      On March 24, 1999 a new corporate entity was incorporated in the state of
      Delaware and all the common shares and warrants of the Company were
      exchanged for shares of the new entity at a ratio of three (3) shares or
      warrants for every two (2) shares or warrants held.

      In March 1999 the new corporate entity commenced a private offering
      consisting of 700,000 shares at a purchase price of $0.10 per share. The
      offering was completed in April 1999.

      In April 1999 the new corporate entity completed another private offering
      consisting of 435,000 shares at a purchase price of $2.00 per share.


                                      F-16


                                     PART II

Item 24. Indemnification of Directors and Officers.

      Article EIGHTH of the Registrant's Certificate of Incorporation, contains
the following provision with respect to the indemnification of directors of the
Company:

            "EIGHTH: The personal liability of the directors of the Corporation
is hereby eliminated to the fullest extent permitted by the provisions of
Section 102(b)(7) of the General Corporation Law of the State of Delaware, as
the same may be amended or supplemented."

      Sections 1, 2, 3 and 4 of Article 8 of the Registrant's By-laws contain
the following provisions with respect to the indemnification of directors,
officers and authorized representatives:

            "Section 1. Indemnification of Directors and Officers in Third Party
Proceedings. The Corporation shall indemnify any director or officer of the
Corporation who was or is an "authorized representative" of the Corporation
(which shall mean for the purposes of this Article a director or officer of the
Corporation, or a person serving at the request of the Corporation as a
director, officer, partner or trustee of another corporation, partnership, joint
venture, trust or other enterprise) and who was or is a "party" (which shall
include for purposes of this Article the giving of testimony or similar
involvement) or is threatened to be made a party to any "third party proceeding
" (which shall mean for purposes of this Article any threatened, pending or
completed action, suit or proceeding, whether civil, criminal, administrative or
investigative, other than an action by or in the right of the Corporation) by
reason of the fact that such person was or is an authorized representative of
the Corporation, against expenses (which shall include for purposes of this
Article attorney's fees and disbursements), judgments, penalties, fines and
amounts paid in settlement actually and reasonably incurred by such person in
connection with such third party proceeding if such person acted in good faith
and in a manner such person reasonably believed to be in, or not opposed to, the
best interests of the Corporation and, with respect to a criminal third party
proceeding (which shall include for purposes of this Article any investigation
which could or does lead to a criminal third party proceeding) had not
reasonable cause to believe such conduct was unlawful. The termination of any
third party proceeding by judgment, order, settlement, indictment, conviction or
upon a plea of no contest or its equivalent, shall not, of itself, create a
presumption that the authorized representative did not act in good faith and in
a manner which such person reasonably believed to be in or not opposed to the
best interests of the Corporation, and, with respect to any criminal third party
proceeding, had reasonable cause to believe that such conduct was unlawful.

            Section 2. Indemnification of Directors and Officers in Corporate
Proceedings. The Corporation shall indemnify any director or officer of the
Corporation who was or is an authorized representative of the Corporation and
who was or is a party or is threatened to be made a party to any "corporate
proceeding" (which shall mean for purposes of this Article any threatened,
pending or completed action or suit by or in the right of the Corporation to
procure a judgment in its favor or any investigative proceeding by or on behalf
of the Corporation) by reason of the fact that such person was or is an
authorized representative of the Corporation, against expenses (including
attorneys' fees and disbursements) actually and reasonably incurred by such
person in connection with the defense or settlement of such corporate proceeding
if such person acted in good faith and in


                                      II-1


a manner such person reasonably believed to be in, or not opposed to, the best
interests of the Corporation, except that no indemnification shall be made in
respect of any claim, issue or matter as to which such person shall have been
adjudged to be liable for negligence or misconduct in the performance of such
person's duty to the Corporation unless and only to the extent that the court in
which such corporate proceeding was pending shall determine upon application
that, despite the adjudication of liability but in view of all the circumstances
of the case, such authorized representative is fairly and reasonably entitled to
indemnity for such expenses which the court shall deem proper.

            Section 3. Indemnification of Authorized Representatives. To the
extent that an authorized representative of the Corporation who neither was nor
is a director or officer of the Corporation has been successful on the merits or
otherwise in defense of any third party or corporate proceeding or in defense of
any claim, issue or matter therein, such person shall be indemnified against
expenses actually and reasonably incurred by such person in connection
therewith. Such an authorized representative may, at the discretion of the
Corporation, be indemnified by the Corporation in any other circumstances to any
extent if the Corporation would be required by Section 1 or 2 of this Article
VIII to indemnify such person in such circumstances to such extent as if such
person were or had been a director or officer of the Corporation.

            Section 4. General Terms. Any indemnification under Section 1 and
Section 2 of this Article VIII (unless ordered by a court) shall be made by the
Corporation only as authorized in the specific case upon a determination that
indemnification of the director, officer, employee or agent is proper in the
circumstances because he had met the applicable standard of conduct set forth in
Section 1 and Section 2 of this Article VIII. Such determination shall be made
(i) by the Board of Directors by a majority vote of a quorum consisting of
directors who were not parties to such action, suit or proceeding, or (ii) if
such a quorum is not obtainable, or, even if obtainable a quorum of
disinterested directors so directs, by independent legal counsel in written
opinion, or (iii) by the stockholders.

            Expenses incurred in defending a civil or criminal action, suit or
proceeding shall be paid by the Corporation in advance of the final disposition
of such action, suit or proceeding upon receipt of an undertaking by or on
behalf of the director, officer, employee or agent to repay such amount if it
shall ultimately be determined that he is not entitled to be indemnified by the
Corporation as authorized in these By-laws.

      Section 145 of the Delaware General Corporation Law also contains
provisions entitling directors and officers of the Company to indemnification
from judgments, fines, amounts paid in settlement and reasonable expenses,
including attorneys' fees, as the result of an action or proceeding in which
they may be involved by reason of being or having been a director or officer of
the Company (or, at the request of the Company,, a director or officer of
another corporation or other enterprise); provided the officers or directors
acted in good faith. The Company also may obtain an insurance policy which will
cover officers and directors for any liability arising out of their actions in
such capacity.

      The foregoing do not and will not eliminate or limit the liability of a
director for violating his duty of loyalty (which includes the obligation of a
director of the Company to refrain from self-dealing with respect to the
Company, improperly competing with the Company or usurping


                                      II-2


Company opportunities), failing to act in good faith, engaging in intentional
misconduct or knowingly violating a law or participating in the payment of a
dividend or a stock repurchase or redemption for himself. The foregoing also do
not and will not affect any director's liability under federal securities laws
or the availability of equitable remedies such as an injunction or rescission
for breach of fiduciary duty.

Item 25. Other Expenses of Issuance and Distribution.

      The following table sets forth an itemized list of all expenses to be
borne by the Registrant in connection with the issuance and distribution of the
securities being registered hereby other than underwriting discounts and
commissions and non-accountable expenses.

SEC Registration Fee...........................................    $    685.73
Printing and Engraving.........................................        1000.00*
Legal Fees and Expenses........................................      35,000.00*
Accounting Fees and Expenses...................................      12,000.00*
Transfer Agent Fees............................................         800.00*
Miscellaneous Expenses.........................................         514.27*

      TOTAL....................................................      50,000.00

- ----------
*     Estimated.

Item 26. Sales of Unregistered Securities.

      Effective April, 1999, the Registrant sold and issued an aggregate of
700,000 shares of Common Stock to a total of seventeen individuals for the
aggregate consideration of $70,000 ($.10 per share). The issuance of all of such
shares of Common Stock did not require registration under the Securities Act in
that all of such shares of Common Stock were issued pursuant to an exemption
from the registration requirements of the Securities Act afforded by Section
3(b) and Rule 504 thereof.

      Effective April, 1999, the Registrant sold and issued an aggregate 435,000
shares of its Common Stock to a total of 32 individuals for the aggregate
consideration of $870,000 ($2.00 per share). All of such shares of Common stock
were issued pursuant to an exemption from the registration requirements of the
Securities Act afforded by Section 3(6) and Rule 504 thereof.

Item 27.    Exhibits.

Number   Description
- ------   -----------

3.1      Articles of Incorporation of Registrant.
3.2      By-Laws of Registrant.
4.1      Specimen Common Stock Certificate.


                                      II-3


5.1+     Opinion of Mintz & Fraade, P.C.
10.1     Employment Agreement of Norman Docteroff
10.2     Marketing and Sales Agreement with Solutions Plus, Inc.
10.3     Management and Consulting Agreement with Rexon Ltd.
21.1     Subsidiary of Registrant
23.1+    Consent of Mintz & Fraade, P.C. (Included in 5.1)
23.2     Consent of BDO Dunwoody
24.1     Power of Attorney (set forth on the signature page of this Registration
         Statement).
27.1     Financial Data Schedule

- ----------
+       To be filed by amendment.

Item 28. Undertakings.

      Insofar as indemnification for liabilities arising under the Securities
Act of 1933, (the "Securities Act") may be permitted to directors, officers and
controlling persons of the Registrant pursuant to any of the provisions
described under Item 24 above, or otherwise, the Registrant has been advised
that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by Registrant of expenses incurred or
paid by a director, officer or controlling person of the Registrant in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will governed by the final
adjudication of such issue.

      The Registrant hereby undertakes that it will:

      (1) File, during any period in which it offers or sells securities, a
      post-effective amendment to this registration statement to:

            (a) include any prospectus required by Section 10(a)(3) of the
            Securities Act;

            (b) reflect in this prospectus any facts or events which,
            individually or in the aggregate, represent a fundamental change in
            the information set forth in the registration statement; and,
            notwithstanding the forgoing, any increase or decrease in volume of
            securities offered (if the total dollar value of securities offered
            would not exceed that which was registered) and any deviation from
            the low or high end of the estimated maximum offering range may be
            reflected in the form of prospectus filed with the Commission
            pursuant to Rule 424(b) if, in the aggregate, the changes in the
            volume and price represent no more than a 20% change in the maximum
            aggregate offering price set forth in the "Calculation of
            Registration Fee" table in the effective registration statement; and


                                      II-4


            (c) Include any additional or changed material information with
            respect to the plan of distribution.

      (2) For determining any liability under the Securities Act, treat each
      post-effective amendment as a new registration statement of the securities
      offered, and the offering of the securities at that time to be the initial
      bona fide offering; and

      The Registrant hereby further undertakes that it will:

      (1) For determining any liability under the Securities Act, treat the
      information omitted from the form of prospectus filed as part of this
      Registration Statement in reliance upon Rule 430A and contained in a form
      of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or
      497(h) under the Securities Act as part of this Registration Statement as
      of the time the Commission declared it effective; and

      (2) For determining any liability under the Securities Act, treat each
      post-effective amendment that contains a form of prospectus as a new
      registration statement for the securities offered in the Registration
      Statement, and that offering of such securities at that time as the
      initial bona fide offering of those securities.


                                      II-5


                                   SIGNATURES

      In accordance with the requirements of the Securities Act of 1933, we
certify that we have reasonable grounds to believe that we meet all of the
requirements of filing on Form SB-2 and authorize this registration statement to
be signed on our behalf by the undersigned, in New York, State of New York,
on July 9, 1999.

                                                DOCUPORT, INC.

                                         By: /s/ Raja S. Tuli
                                             -----------------------------------
                                             Raja S. Tuli, Chairman of the Board

                                         By: /s/ Norman Docteroff
                                             -----------------------------------
                                                Norman Docteroff, President

                                POWER OF ATTORNEY

      We, the undersigned officers and directors of Docuport, Inc., hereby
severally constitute and appoint Norman Docteroff and Raja S. Tuli, and each of
them (with full power to each of them to act alone), our true and lawful
attorneys-in-fact and agents, with full power of substitution, for us and in our
stead, in any and all capacities, to sign any and all amendments (including
pre-effective and post-effective amendments) to this Registration Statement and
all documents in connection thereto, and to file the same, with all exhibits
thereto, and other documents in connection therewith, with the Securities and
Exchange Commission, granting to said attorneys-in-fact and agents, and each of
them, full power and authority to do and perform each and every act and thing
necessary or advisable to be done in and about the premises, as full to all
intents and purposes as he or she might or could do in person, hereby ratifying
and confirming all the said attorneys-in-fact and agents, or any of them, or
their substitute or substitutes may lawfully do or cause to be done by virtue
hereof.

      In accordance with the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates stated.

             Name                           Title                     Date
             ----                           -----                     ----

                                  President, Chief Executive
/s/ Norman Docteroff              Officer and Director            July 2, 1999
- ------------------------------
       Norman Docteroff

/s/ Raja S. Tuli                  Director                        July 9, 1999
- ------------------------------
         Raja S. Tuli

/s/ Madan G. Tuli                 Director                        July 9, 1999
- ------------------------------
         Madan G. Tuli

/s/ Lakhbir Tuli                  Director                        July 9, 1999
- ------------------------------
         Lakhbir Tuli